
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A45000016A7247547E3.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="molpharm" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC6877291/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877291/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Molecular Pharmacology" /><meta name="citation_title" content="Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism" /><meta name="citation_author" content="Aamod S. Dekhne" /><meta name="citation_author" content="Changwen Ning" /><meta name="citation_author" content="Md. Junayed Nayeen" /><meta name="citation_author" content="Khushbu Shah" /><meta name="citation_author" content="Hasini Kalpage" /><meta name="citation_author" content="Josephine Fr&#x000fc;hauf" /><meta name="citation_author" content="Adrianne Wallace-Povirk" /><meta name="citation_author" content="Carrie O&#x02019;Connor" /><meta name="citation_author" content="Zhanjun Hou" /><meta name="citation_author" content="Seongho Kim" /><meta name="citation_author" content="Maik H&#x000fc;ttemann" /><meta name="citation_author" content="Aleem Gangjee" /><meta name="citation_author" content="Larry H. Matherly" /><meta name="citation_publication_date" content="2020/01" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="97" /><meta name="citation_firstpage" content="9" /><meta name="citation_doi" content="10.1124/mol.119.117937" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC6877291/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC6877291/" /><meta name="citation_pmid" content="31707355" /><meta name="DC.Title" content="Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="American Society for Pharmacology and Experimental Therapeutics" /><meta name="DC.Contributor" content="Aamod S. Dekhne" /><meta name="DC.Contributor" content="Changwen Ning" /><meta name="DC.Contributor" content="Md. Junayed Nayeen" /><meta name="DC.Contributor" content="Khushbu Shah" /><meta name="DC.Contributor" content="Hasini Kalpage" /><meta name="DC.Contributor" content="Josephine Fr&#x000fc;hauf" /><meta name="DC.Contributor" content="Adrianne Wallace-Povirk" /><meta name="DC.Contributor" content="Carrie O&#x02019;Connor" /><meta name="DC.Contributor" content="Zhanjun Hou" /><meta name="DC.Contributor" content="Seongho Kim" /><meta name="DC.Contributor" content="Maik H&#x000fc;ttemann" /><meta name="DC.Contributor" content="Aleem Gangjee" /><meta name="DC.Contributor" content="Larry H. Matherly" /><meta name="DC.Date" content="2020 Jan" /><meta name="DC.Identifier" content="10.1124/mol.119.117937" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism" /><meta property="og:type" content="article" /><meta property="og:description" content="Folate-dependent one-carbon (C1) metabolism is compartmentalized in the mitochondria and cytosol and is a source of critical metabolites for proliferating tumors. Mitochondrial C1 metabolism including serine hydroxymethyltransferase 2 (SHMT2) generates ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877291/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6877291/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Mol Pharmacol%22[journal]" class="navlink">Molecular Pharmacology</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC6877291
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC6877291/pdf/mol.119.117937.pdf" class="int-view">PDF (1.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/6877291/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/6877291/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="6877291" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6877291%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="OqpBGrwgE68xD0HXzgfY4gsWs6QcaWbicDMHaQuA1KmAnNtzJEDfYgfcjKBHdrzO">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6877291%2F&amp;text=Cellular%20Pharmacodynamics%20of%20a%20Novel%20Pyrrolo%5B3%2C2-d%5Dpyrimidine%20Inhibitor%20Targeting%20Mitochondrial%20and%20Cytosolic%20One-Carbon%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6877291%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877291/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC6877291/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/31707355/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC6877291/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/31707355/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC6877291/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/6877291/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Mol Pharmacol%22[journal]" class="navlink">Molecular Pharmacology</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC6877291
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-molpharm.png" alt="Logo of molpharm" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://molpharm.aspetjournals.org/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Mol Pharmacol.</span> 2020 Jan; 97(1): 9–22. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2020 Jan. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1124%2Fmol.119.117937" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1124/mol.119.117937</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC6877291</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31707355">31707355</a></div></div></div><h1 class="content-title">Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-<em>d</em>]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism<sup><a href="#FN5" rid="FN5" class=" fn"><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is sbox.jpg" src="/pmc/articles/PMC6877291/bin/sbox.jpg" /></a></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Dekhne%20AS%5BAuthor%5D">Aamod S. Dekhne</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ning%20C%5BAuthor%5D">Changwen Ning</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Nayeen%20MJ%5BAuthor%5D">Md. Junayed Nayeen</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shah%20K%5BAuthor%5D">Khushbu Shah</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kalpage%20H%5BAuthor%5D">Hasini Kalpage</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fr&#x000fc;hauf%20J%5BAuthor%5D">Josephine Fr&#x000fc;hauf</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wallace-Povirk%20A%5BAuthor%5D">Adrianne Wallace-Povirk</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=O&#x02019;Connor%20C%5BAuthor%5D">Carrie O&#x02019;Connor</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hou%20Z%5BAuthor%5D">Zhanjun Hou</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kim%20S%5BAuthor%5D">Seongho Kim</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=H&#x000fc;ttemann%20M%5BAuthor%5D">Maik H&#x000fc;ttemann</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Gangjee%20A%5BAuthor%5D">Aleem Gangjee</a>,<sup></sup><sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Matherly%20LH%5BAuthor%5D">Larry H. Matherly</a><sup></sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140247882935984_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140247882935984_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140247882935984_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140247882935984_ai" style="display:none"><div class="fm-affl" id="aff-a.q.b.e.n">Department of Oncology, Wayne State University School of Medicine/Karmanos Cancer Institute, Detroit, Michigan (A.S.D., J.F., A.W.-P., C.O., Z.H., S.K., L.H.M.); Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania (M.J.N., K.S., A.G.); Center for Molecular Medicine and Genetics (H.K., M.H.) and Department of Pharmacology (L.H.M.), Wayne State University School of Medicine, Detroit, Michigan; Biochemistry and Molecular Biology, Jilin University, Changchun, Jilin Province, China (C.N.); and Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan (Z.H., S.K., M.H., L.H.M.)</div><div id="cor1"><strong>Address correspondence to:</strong> Dr. Larry H. Matherly, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 421 East Canfield Ave, Detroit, MI 48201.,  E-mail: <a href="mailto:dev@null" data-email="gro.sonamrak@ylrehtam" class="oemail">gro.sonamrak@ylrehtam</a>; or </div><div id="cor2">Dr. Aleem Gangjee, Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282.,  E-mail: <a href="mailto:dev@null" data-email="ude.qud@eejgnag" class="oemail">ude.qud@eejgnag</a></div><div id="FN1"><sup>1</sup>A.S.D. and C.N. contributed equally.</div><div id="FN2"><sup>2</sup>A.G. and L.H.M. contributed equally.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140247882935984_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2019 Jul 24; Accepted 2019 Oct 23.</div></div><div class="permissions half_rhythm hide" id="idm140247882935984_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2019 by The American Society for Pharmacology and Experimental Therapeutics</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.q.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.q.b.rtitle">Abstract</h2><!--article-meta--><div><p class="p p-first">Folate-dependent one-carbon (C1) metabolism is compartmentalized in the mitochondria and cytosol and is a source of critical metabolites for proliferating tumors. Mitochondrial C1 metabolism including serine hydroxymethyltransferase 2 (SHMT2) generates glycine for de novo purine nucleotide and glutathione biosynthesis and is an important source of NADPH, ATP, and formate, which affords C1 units as 10-formyl-tetrahydrofolate and 5,10-methylene-tetrahydrofolate for nucleotide biosynthesis in the cytosol. We previously discovered novel first-in-class multitargeted pyrrolo[3,2-<em>d</em>]pyrimidine inhibitors of SHMT2 and de novo purine biosynthesis at glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase with potent in vitro and in vivo antitumor efficacy toward pancreatic adenocarcinoma cells. In this report, we extend our findings to an expanded panel of pancreatic cancer models. We used our lead analog <strong>AGF347</strong> [(4-(4-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)butyl)-2-fluorobenzoyl)-<span class="small-caps">l</span>-glutamic acid] to characterize pharmacodynamic determinants of antitumor efficacy for this series and demonstrated plasma membrane transport into the cytosol, uptake from cytosol into mitochondria, and metabolism to <strong>AGF347</strong> polyglutamates in both cytosol and mitochondria. Antitumor effects of <strong>AGF347</strong> downstream of SHMT2 and purine biosynthesis included suppression of mammalian target of rapamycin signaling, and glutathione depletion with increased levels of reactive oxygen species. Our results provide important insights into the cellular pharmacology of novel pyrrolo[3,2-<em>d</em>]pyrimidine inhibitors as antitumor compounds and establish <strong>AGF347</strong> as a unique agent for potential clinical application for pancreatic cancer, as well as other malignancies.</p><div id="sec-a.q.b.r.b" class="sec"><h3 id="sec-a.q.b.r.btitle">SIGNIFICANCE STATEMENT</h3><p class="p p-first-last">This study establishes the antitumor efficacies of novel inhibitors of serine hydroxymethyltransferase 2 and of cytosolic targets toward a panel of clinically relevant pancreatic cancer cells and demonstrates the important roles of plasma membrane transport, mitochondrial accumulation, and metabolism to polyglutamates of the lead compound <strong>AGF347</strong> to drug activity. We also establish that loss of serine catabolism and purine biosynthesis resulting from <strong>AGF347</strong> treatment impacts mammalian target of rapamycin signaling, glutathione pools, and reactive oxygen species, contributing to antitumor efficacy.</p></div></div></div><div id="abstract-a.q.b.s" lang="en" class="tsec sec"><h2 class="headless nomenu"></h2><!--article-meta--><div><p class="p p-first-last"><!--fig ft0--><!--fig mode=article f1--></p><div class="fig iconblock whole_rhythm" id="absf1" co-legend-rid="lgnd_absf1"><a href="/pmc/articles/PMC6877291/figure/absf1/" target="figure" rid-figpopup="absf1" rid-ob="ob-absf1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247887306032"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937absf1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937absf1.jpg" src="/pmc/articles/PMC6877291/bin/mol.119.117937absf1.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140247887306032"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/absf1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_absf1"></div></div><p></p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">The malignant phenotype depends on reprogramming cellular metabolism, including the one-carbon (C1) metabolic pathway (<a href="#B18" rid="B18" class=" bibr popnode">Hanahan and Weinberg, 2011</a>; <a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>; <a href="#B46" rid="B46" class=" bibr popnode">Newman and Maddocks, 2017</a>). C1 metabolism is compartmentalized in the cytosol and mitochondria (<a href="/pmc/articles/PMC6877291/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>) and generates amino acids and nucleotides essential for cell proliferation and tumor progression (<a href="#B59" rid="B59" class=" bibr popnode">Tibbetts and Appling, 2010</a>; <a href="#B67" rid="B67" class=" bibr popnode">Yang and Vousden, 2016</a>; <a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>). C1 pathways depend on tetrahydrofolate (THF) cofactors that mediate transfer of C1 units. In mammalian cells, folates are acquired from exogenous sources and are transported into cells by the reduced folate carrier (RFC) and the proton-coupled folate transporter (PCFT) (<a href="/pmc/articles/PMC6877291/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>), and by folate receptors (not depicted) (<a href="#B36" rid="B36" class=" bibr popnode">Matherly et al., 2007</a>; <a href="#B71" rid="B71" class=" bibr popnode">Zhao et al., 2011</a>). Once internalized, folates are translocated from the cytosol into mitochondria by the mitochondrial folate transporter (MFT) (SLC25A32) (<a href="#B39" rid="B39" class=" bibr popnode">McCarthy et al., 2004</a>). In both the cytosol and mitochondria, folates are polyglutamylated by folylpoly-<em>&#x003b3;</em>-glutamate synthetase (FPGS), and these polyglutamyl metabolites do not exchange between compartments (<a href="#B26" rid="B26" class=" bibr popnode">Lawrence et al., 2014</a>). Polyglutamylation of folates confers increased rates of C1 transfer, and polyglutamyl folate forms show enhanced cellular retention over monoglutamyl folates (<a href="#B55" rid="B55" class=" bibr popnode">Shane, 1989</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC6877291/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247879918256"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247879918256"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig. 1.</a></div><!--caption a7--><div class="caption"><p>C1 metabolism is compartmentalized in the cytosol and the mitochondria. Folates (and folate analogs) enter the cell through plasma membrane folate transporters including PCFT and RFC. Folates then enter the mitochondria by MFT (SLC25A32). Serine catabolism occurs in the mitochondria beginning with SHMT2 to generate glycine and formate. Glycine is used for synthesis of proteins, purines, and GSH, whereas formate is critical for downstream cytosolic C1 metabolism following formation of 10-formyl-THF. 10-Formyl-THF serves as a C1 donor for the steps catalyzed by GARFTase and AICARFTase in de novo purine nucleotide biosynthesis. Formate is also converted to 5,10-methylene (me) THF by 5,10-me-THF dehydrogenase 1 (MTHFD1), which is the cofactor for thymidylate synthase (TS). Arrows indicate the net flux of C1 metabolism, but most reactions in the serine/glycine cycle are reversible. Also shown is the SHMT1 reaction in cytosol, which generates serine from glycine and 5,10-me-THF, and the inactivation of ROS by GSH. DHFR, dihydrofolate reductase; PRPP, phosphoribosyl pyrophosphate.</p></div></div></div><p>C1 metabolic enzymes in the mitochondria include serine hydroxymethyltransferase 2 (SHMT2), 5,10-methylene THF dehydrogenase 2 (MTHFD2), and 10-formyl THF synthetase (reverse) (MTHFD1L) (<a href="/pmc/articles/PMC6877291/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>). The serine catabolic pathway is nearly universally activated in cancer, with SHMT2 and MTHFD2 among the most differentially expressed metabolic genes in all human cancers (<a href="#B20" rid="B20" class=" bibr popnode">Jain et al., 2012</a>; <a href="#B47" rid="B47" class=" bibr popnode">Nilsson et al., 2014</a>). The pathway for serine catabolism and glycine synthesis occurs in the mitochondria, and the 3-carbon of serine is the major C1 donor for de novo biosynthesis of purines and thymidylate in the cytosol (<a href="#B59" rid="B59" class=" bibr popnode">Tibbetts and Appling, 2010</a>; <a href="#B67" rid="B67" class=" bibr popnode">Yang and Vousden, 2016</a>; <a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>). Synthesis of 10-formyl THF from mitochondrial formate and THF in the cytosol stabilizes cytosolic THF from degradation (<a href="#B73" rid="B73" class=" bibr popnode">Zheng et al., 2018</a>). The mitochondrial C1 pathway also generates critical reducing equivalents [as NAD(P)H] to sustain redox balance in hypoxic tumors (<a href="#B68" rid="B68" class=" bibr popnode">Ye et al., 2014</a>; <a href="#B69" rid="B69" class=" bibr popnode">Zhang et al., 2016a</a>) and is an important source of ATP (<a href="#B40" rid="B40" class=" bibr popnode">Meiser et al., 2016</a>). Genetic deletion of SHMT2 in cultured cells results in defective mitochondrial respiration due to impaired synthesis of respiratory chain proteins (<a href="#B42" rid="B42" class=" bibr popnode">Minton et al., 2018</a>; <a href="#B44" rid="B44" class=" bibr popnode">Morscher et al., 2018</a>), accompanied by increased glycolytic flux (<a href="#B44" rid="B44" class=" bibr popnode">Morscher et al., 2018</a>). Cells deficient in mitochondrial C1 metabolism or MFT transport are glycine auxotrophs (<a href="#B39" rid="B39" class=" bibr popnode">McCarthy et al., 2004</a>; <a href="#B59" rid="B59" class=" bibr popnode">Tibbetts and Appling, 2010</a>; <a href="#B21" rid="B21" class=" bibr popnode">Kim et al., 2015</a>; <a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>).</p><p>Evidence of a critical role for serine catabolism as a source of C1 units for cytosolic anabolism (<a href="#B67" rid="B67" class=" bibr popnode">Yang and Vousden, 2016</a>; <a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>; <a href="#B46" rid="B46" class=" bibr popnode">Newman and Maddocks, 2017</a>), combined with the unique demands of tumor cells for glycine and redox balance versus those of normal tissues (<a href="#B20" rid="B20" class=" bibr popnode">Jain et al., 2012</a>; <a href="#B11" rid="B11" class=" bibr popnode">Ducker et al., 2016</a>; <a href="#B31" rid="B31" class=" bibr popnode">Loayza-Puch et al., 2016</a>), suggests that SHMT2 could be an independent prognostic factor and potential therapeutic target for cancer. Elevated SHMT2 is associated with poor prognoses of breast cancers and gliomas (<a href="#B70" rid="B70" class=" bibr popnode">Zhang et al., 2016b</a>; <a href="#B61" rid="B61" class=" bibr popnode">Wang et al., 2017</a>; <a href="#B66" rid="B66" class=" bibr popnode">Wu et al., 2017</a>). In patients who underwent surgical resection of pancreatic adenocarcinomas, elevated SHMT2 was associated with poor overall survival and disease-free survival compared with patients with low SHMT2 (<a href="#B48" rid="B48" class=" bibr popnode">Noguchi et al., 2018</a>).</p><p>We recently described novel 5-substituted pyrrolo[3,2-<em>d</em>]pyrimidine compounds, <strong>AGF291</strong> [(4-(3-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)propyl)benzoyl)-<span class="small-caps">l</span>-glutamic acid], <strong>AGF320</strong> [(5-(5-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)pentyl)thiophene-2-carbonyl)-<span class="small-caps">l</span>-glutamic acid], and <strong>AGF347</strong> [(4-(4-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)butyl)-2-fluorobenzoyl)-<span class="small-caps">l</span>-glutamic acid], as anticancer agents (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). Direct inhibition of SHMT2 in mitochondria and targeting of SHMT1 and de novo purine biosynthesis [at glycinamide ribonucleotide and 5-aminoimidazole-4-carboxamide (AICA) ribonucleotide formyltransferases (GARFTase and AICARFTase, respectively)] in cytosol were established in colon and lung cancer cells, as well as in pancreatic cancer (PaC) models. For early and late-stage MIA PaCa-2 (an aggressive PaC model) tumor xenograft models treated with <strong>AGF347</strong>, impressive in vivo antitumor efficacy with curative potential was accompanied by minimal toxicity, and enzyme targets were validated by metabolomics analysis and in vitro enzyme assays (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>).</p><p class="p">In this report, we explore the cellular pharmacodynamics of this series with a focus on <strong>AGF347</strong> (<a href="/pmc/articles/PMC6877291/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>). Our studies establish broad-spectrum in vitro antitumor efficacy against a panel of PaC models and demonstrate the critical roles of plasma membrane transport, mitochondrial accumulation, and conversion to polyglutamates in both cytosol and mitochondria in effecting antitumor activity. We also explore mechanisms of antitumor activity of pyrrolo[3,2-<em>d</em>]pyrimidine compounds, including the impact of loss of serine catabolism and purine biosynthesis resulting from <strong>AGF347</strong> (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) on AMP-activated protein kinase (AMPK) activation and mammalian target of rapamycin (mTOR) signaling, mitochondrial respiration, and glutathione pools and levels of reactive oxygen species (ROS). Collectively, our results underscore the unique pharmacology of this novel series and establish <strong>AGF347</strong> as a promising new therapeutic for cancer.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC6877291/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247933212656"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247933212656"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig. 2.</a></div><!--caption a7--><div class="caption"><p>In vitro antitumor efficacy and identification of targeted pathways and enzymes by <strong>AGF347</strong> in BxPC-3 and HPAC tumor cells by proliferation assays and adenosine/glycine rescue. Dose-response growth inhibition curves are shown for <strong>AGF347</strong> (structure shown) without additions, or in the presence of adenosine (60 <em>&#x003bc;</em>M) and/or glycine (130 <em>&#x003bc;</em>M). The results are mean &#x000b1; S.D. values for three biologic replicates.</p></div></div></div></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s3" class="sec sec-first-last"><div id="s4" class="sec sec-first"><p></p><h4 id="s4title" class="inline">Chemicals. </h4><p class="p p-first-last">[<sup>3</sup>H]<strong>AGF347</strong> (9 Ci/mmol), [<sup>3</sup>H]methotrexate (MTX; 10&#x02013;30 Ci/mmol), and [<sup>3</sup>H]folic acid (32.9 Ci/mmol) were purchased from Moravek Biochemicals (Brea, CA). Leucovorin [(6R,S) 5-formyl tetrahydrofolate] and MTX were provided by the Drug Development Branch, National Cancer Institute (Bethesda, MD). Pemetrexed (PMX) was purchased from LC Laboratories (Woburn, MA). Gemcitabine was obtained from Pfizer (New York, NY). PT523 [<em>N</em><sup><em>&#x003b1;</em></sup>-(4-amino-4-deoxypteroyl)-<em>N</em><sup><em>&#x003b4;</em></sup>-hemiphthaloyl-l-ornithine] was a gift from Dr. Andre Rosowsky (Dana-Farber Cancer Institute, Boston, MA). Other chemicals were obtained from commercial sources in the highest available purities. <strong>AGF94</strong> (<em>N</em>-((5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-<em>d</em>]pyrimidin-6-yl)propyl]thiophen-2-yl)carbonyl)-<span class="small-caps">l</span>-glutamic acid), <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong> were synthesized as previously described (<a href="#B62" rid="B62" class=" bibr popnode">Wang et al., 2011</a>; <a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>).</p></div><div id="s5" class="sec"><p></p><h4 id="s5title" class="inline">Cell Culture. </h4><p class="p p-first">The HCT116 cell lines, including the SHMT1 and SHMT2 knockout (KO) cells (<a href="#B11" rid="B11" class=" bibr popnode">Ducker et al., 2016</a>; <a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>), were generously provided by G. S. Ducker and J. D. Rabinowitz (Princeton University). KB cells were purchased from the American Type Culture Collection (Manassas, VA) and were cultured as previously described (<a href="#B8" rid="B8" class=" bibr popnode">Deng et al., 2008</a>). PaC cell lines, including AsPC-1 (<a href="#B5" rid="B5" class=" bibr popnode">Chen et al., 1982</a>), BxPC-3 (<a href="#B58" rid="B58" class=" bibr popnode">Tan et al., 1986</a>), CFPAC-1 (<a href="#B54" rid="B54" class=" bibr popnode">Schoumacher et al., 1990</a>), HPAC (<a href="#B16" rid="B16" class=" bibr popnode">Gower et al., 1994</a>), and MIA PaCa-2 (<a href="#B65" rid="B65" class=" bibr popnode">Wu et al., 1977</a>), were generously provided by Dr. Yubin Ge (Karmanos Cancer Institute, Detroit, MI). Human pancreatic normal epithelial (HPNE) cells (<a href="#B27" rid="B27" class=" bibr popnode">Lee et al., 2003</a>) were a gift from M. Oulette (University of Nebraska Medical Center, Omaha, NE). Cell lines were validated by short tandem repeat analysis by Genetica DNA Laboratories (Burlington, NC). MTXRIIOua<sup>R</sup>2-4 (i.e., R2) CHO cells were provided by Dr. Wayne Flintoff (University of Western Ontario) (<a href="#B15" rid="B15" class=" bibr popnode">Flintoff et al., 1976</a>). From the parental R2 cell line, human RFC and PCFT were individually transfected to generate the isogenic CHO cell lines designated PC43-10 (RFC) and R2/PCFT4 (PCFT) (<a href="#B64" rid="B64" class=" bibr popnode">Wong et al., 1995</a>; <a href="#B8" rid="B8" class=" bibr popnode">Deng et al., 2008</a>, <a href="#B9" rid="B9" class=" bibr popnode">2009</a>). glyB cells were a generous gift from Dr. Larry Chasin (Columbia University). glyBTII cells were derived from glyB cells by electroporation with human MFT cDNAs in a pcDNA3.1(&#x02212;)/myc-His6 A&#x02013;tagged vector. Transfectants were selected with G418, and colonies were isolated and expanded for screening by Western blot and real-time reverse-transcription polymerase chain reaction (RT-PCR) analyses.</p><p>The PaC cell lines were cultured in RPMI 1640 medium, supplemented with 10% FBS (Sigma-Aldrich, St. Louis, MO) and 1% penicillin/streptomycin (Life Technologies) at 37&#x000b0;C with 5% CO<sub>2</sub>. The R1-11 RFC- and PCFT-null HeLa subline was a gift from Dr. I. David Goldman (Albert Einstein School of Medicine, Bronx, NY) (<a href="#B72" rid="B72" class=" bibr popnode">Zhao et al., 2009</a>). The R1-11 RFC2 cell line was developed in our laboratory by transfection of R1-11 cells with the pZeoSV2-RFC vector and clonal selection (<a href="#B63" rid="B63" class=" bibr popnode">Wang et al., 2015</a>). For nontransport experiments, the aforementioned cell lines were maintained in folate-free RPMI 1640 (FFRPMI) supplemented with 10% dialyzed FBS (Sigma-Aldrich), 1% penicillin/streptomycin solution, 2 mM <span class="small-caps">l</span>-glutamine, and 25 nM leucovorin. Cell proliferation assays in CHO cells were performed as described in complete FFRPMI without glycine. Glycine/adenosine rescue experiments were performed in BxPC-3 and HPAC cells without additions, or in the presence of adenosine (60 <em>&#x000b5;</em>M) and/or glycine (130 <em>&#x000b5;</em>M) (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>).</p><p>Cell lines were tested for <em>Mycoplasma</em> by PCR using a <em>Mycoplasma</em> testing kit (Venor GeM Mycoplasma Detection Kit; Sigma-Aldrich) (Test date: February 2018) and frozen in aliquots in liquid nitrogen. As warranted, cells were treated (Plasmocin; InvivoGen) and retested for <em>Mycoplasma</em>. To avoid cell line &#x0201c;drift,&#x0201d; fresh cultures were reconstituted no less than every month from the original freezer stocks (aforementioned).</p><p class="p p-last">For transport experiments (see <em>Membrane Transport Assays</em>), cells were maintained in RPMI 1640 supplemented with 10% FBS, 1% penicillin/streptomycin solution, and 2 mM <span class="small-caps">l</span>-glutamine. R1-11 cells were maintained under continuous selection with 500 <em>&#x000b5;</em>M MTX and 1 mg/ml G418. R1-11 RFC2 cells were maintained under continuous selection with 100 <em>&#x000b5;</em>g/ml Zeocin (Thermo Fisher). CHO cell lines were maintained in <em>&#x003b1;</em>-minimal essential medium (<em>&#x003b1;</em>MEM) supplemented with 10% bovine calf serum, 1% penicillin/streptomycin solution, and 2 mM <span class="small-caps">l</span>-glutamine in a humidified atmosphere at 37&#x000b0;C in the presence of 5% CO<sub>2</sub> and 95% air. Additionally, the transfected CHO cell lines (i.e., R2/PCFT4 and glyBTII) were maintained under continuous selection with 1 mg/ml G418.</p></div><div id="s6" class="sec"><p></p><h4 id="s6title" class="inline">Generation of MIA PaCa-2 MFT Knockdown Cell Line. </h4><p class="p p-first-last">MIA PaCa-2 cells were seeded (2 &#x000d7; 10<sup>5</sup> cells/well) in 24-well plates containing 1 ml of culture medium (i.e., FFRPMI supplemented with 10% dialyzed FBS, 1% penicillin/streptomycin, 2 mM <span class="small-caps">l</span>-glutamine, and 25 nM leucovorin). Cells were treated with 4 <em>&#x003bc;</em>g/ml polybrene and 10<sup>5</sup> transducing units of MISSION Lentiviral particles (Sigma-Aldrich) containing short hairpin RNA targeting MFT (TRCN0000043091). After 24 hours, the medium was replaced with fresh complete FFRPMI medium including 2 <em>&#x003bc;</em>g/ml puromycin as a selection marker. Once cells were confluent, the cells were harvested, passaged three to four times, and then assayed by RT-PCR for MFT knockdown relative to nontargeted control (NTC) particle-transduced MIA PaCa-2 cells. To isolate single clones, cells were plated in 100-mm dishes (200 cells/dish) in the presence of 2 <em>&#x003bc;</em>g/ml puromycin. Colonies were isolated, expanded (in RPMI 1640 supplemented with 10% FBS, 1% penicillin/streptomycin, and 2 mM <span class="small-caps">l</span>-glutamine), and clonal cultures were assayed for MFT knockdown via RT-PCR.</p></div><div id="s7" class="sec"><p></p><h4 id="s7title" class="inline">Gel Electrophoresis and Western Blots. </h4><p class="p p-first">glyB and glyBTII cells were cultured in two T150 flasks each and harvested when cells were &#x0223c;90% confluent. Mitochondrial fractions were isolated (see <em>Subcellular Fractionation Assays of Cytosolic and Mitochondrial <strong>AGF347</strong></em>) and assayed for protein concentrations (<a href="#B32" rid="B32" class=" bibr popnode">Lowry et al., 1951</a>). Equal amounts of protein (36 <em>&#x000b5;</em>g) from each sample were electrophoresed on 10% polyacrylamide gels with SDS (<a href="#B24" rid="B24" class=" bibr popnode">Laemmli, 1970</a>) and transferred to polyvinylidene difluoride membranes (Thermo Fisher) (<a href="#B38" rid="B38" class=" bibr popnode">Matsudaira, 1987</a>). To detect MFT (myc-his6) expression, the membranes were incubated for 24 hours with rabbit anti-myc primary antibody (MMS-150P; Covance Inc., Princeton, NJ), then with IRDye 800CW&#x02013;conjugated goat anti-rabbit IgG secondary antibody (925-32211; LICOR Biosciences, Omaha, NE) for 90 minutes. The blots were scanned with an Odyssey infrared imaging system (LICOR Biosciences). The membrane was prestained with Coomassie Blue as a loading control.</p><p class="p p-last">For assays of AMPK and mTOR signaling, total and phospho-AMPK (P-AMPK) and total and phosphorylated S6K1 (P-p70- and P-p80-S6K1) were analyzed by Western blotting (<a href="#B43" rid="B43" class=" bibr popnode">Mitchell-Ryan et al., 2013</a>). In brief, HPAC and BxPC-3 cells (1 million cells/dish for vehicle-treated samples, 1.5 million cells/dish for drug-treated samples) were seeded in 60-mm dishes in 5 ml of FFRPMI supplemented with 10% dialyzed FBS, 1% penicillin/streptomycin, 2 mM <span class="small-caps">l</span>-glutamine, and 25 nM leucovorin. Cells were allowed to adhere for 24 hours, after which 10 <em>&#x000b5;</em>M <strong>AGF347</strong>, 1 mM AICA ribonucleoside (AICAR), or a comparable volume of vehicle (DMSO) was added. Incubations were performed at 37&#x000b0;C with 5% CO<sub>2</sub>. After 48 hours, cells were harvested and disrupted by sonication; cell debris was removed by centrifugation (1800 rpm, 5 minutes, 4&#x000b0;C). The soluble cell fractions were assayed for protein concentration (<a href="#B32" rid="B32" class=" bibr popnode">Lowry et al., 1951</a>), and equal protein (50 <em>&#x000b5;</em>g) from each sample was electrophoresed on 10% polyacrylamide gels with SDS and transferred to polyvinylidene difluoride membranes. To detect phospho- or total AMPK, or p70-S6K1/p85-S6K1, membranes were incubated for 24 hours with rabbit primary antibody [total AMPK, 5831S; P-AMPK, T172, 2535S; total p70-S6K1/p85-S6K1, 2708S; P-p70-S6K1/P-p80-S6K1 (T389/T412), 9234S; Cell Signaling Technology, Danvers, MA]. The blots were stripped (25 mM glycine, pH 2.0, 1% to 2% SDS) to remove bound antibodies between probing with different antibodies. The blots were developed by incubating in IRDye 800CW&#x02013;conjugated goat anti-rabbit IgG secondary antibody (925-32211; LICOR Biosciences) for 90 minutes and scanned with an Odyssey infrared imaging system (LICOR Biosciences). Protein loading was normalized to <em>&#x003b2;</em>-actin using anti-<em>&#x003b2;</em>-actin mouse primary antibody (A2228; Sigma-Aldrich) and IRDye 800CW&#x02013;conjugated goat anti-mouse IgG secondary antibody (926-32210; LICOR Biosciences). Densitometry used Image Studio Software (LICOR Biosciences). For densitometry of S6K1, both p70 and p85 bands were quantified. All blots were run at least in duplicate, and densitometry data are reported as average values plus/minus ranges.</p></div><div id="s8" class="sec"><p></p><h4 id="s8title" class="inline">Real-Time PCR. </h4><p class="p p-first-last">Cells were harvested from either 60-mm dishes or T25 flasks at &#x0223c;80% confluence, and RNAs were extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). cDNAs were synthesized with random hexamers, MuLV reverse transcriptase, and RNase inhibitor (Applied Biosystems, Waltham, MA) and purified with a QIAquick PCR Purification Kit (QIAGEN, Valencia, CA). Quantitative real-time RT-PCR used a Roche LightCycler 480 (Roche Diagnostics, Indianapolis, IN) with gene-specific primers and SYBR Green I dye. Transcript levels were normalized to <em>&#x003b2;</em>-actin and/or glyceraldehyde-3-phosphate dehydrogenase transcripts. Primer sequences are available upon request.</p></div><div id="s9" class="sec"><p></p><h4 id="s9title" class="inline">Membrane Transport Assays. </h4><p class="p p-first-last">Plasma membrane transport measurements were performed at 37&#x000b0;C as previously described (<a href="#B50" rid="B50" class=" bibr popnode">Ravindra et al., 2018</a>). Buffers used were MES [2-(<em>N</em>-morpholino)ethanesulfonic acid]&#x02013;buffered saline at pH 5.5 (20 mM MES, 140 mM NaCl, 5 mM KCl, 2 mM MgCl<sub>2</sub>, and 5 mM glucose) and HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid]&#x02013;buffered saline at pH 6.8 and pH 7.2 (20 mM HEPES, 140 mM NaCl, 5 mM KCl, 2 mM MgCl<sub>2</sub>, and 5 mM glucose). For some experiments, anion-free buffer at pH 7.2 (20 mM HEPES and 235 mM sucrose) was used. For standard transport experiments, cells were seeded in 60-mm dishes and assayed for uptake when cells were 75%&#x02013;90% confluent with 0.5 <em>&#x000b5;</em>M [<sup>3</sup>H]MTX or [<sup>3</sup>H]<strong>AGF347</strong> at 37&#x000b0;C over 2&#x02013;5 minutes. For the PaC cell lines, uptake was measured at pH 5.5, 6.8, and 7.2 using MES-buffered (pH 5.5) and HEPES-buffered (pH 6.8 and 7.2) saline. Uptake assays in the presence of excess (10 <em>&#x000b5;</em>M) nonradioactive <strong>AGF94</strong> (<a href="#B62" rid="B62" class=" bibr popnode">Wang et al., 2011</a>) (blocks PCFT uptake) and/or PT523 (<a href="#B51" rid="B51" class=" bibr popnode">Rosowsky, 1999</a>) (blocks RFC uptake) were performed to establish transport specificities. Calculations of K<sub>m</sub> and V<sub>max</sub> were performed with concentrations of [<sup>3</sup>H]<strong>AGF347</strong> or [<sup>3</sup>H]MTX from 20 to 500 nM for R2/PCFT4 cells (at pH 5.5 in MES-buffered saline) or from 250 nM to 5 <em>&#x000b5;</em>M for R1-11 RFC2 cells (at pH 7.2 in anion-free buffer). K<sub>m</sub> and V<sub>max</sub> values were calculated by Lineweaver-Burk plots. K<sub>i</sub> values for each of the drugs relative to 0.5 <em>&#x000b5;</em>M [<sup>3</sup>H]MTX were calculated from Dixon plots using concentrations of non-radioactive competitor (e.g., <strong>AGF347</strong>) from 0 to 500 nM (R2/PCFT4 at pH 5.5 in MES-buffered saline) or 0 to 1 <em>&#x000b5;</em>M (R1-11 RFC2 at pH 7.2 in anion-free buffer).</p></div><div id="s10" class="sec"><p></p><h4 id="s10title" class="inline">Subcellular Fractionation Assays of Cytosolic and Mitochondrial AGF347. </h4><p class="p p-first-last">Cells were cultured in complete <em>&#x003b1;</em>MEM supplemented with 10% bovine calf serum (Thermo Fisher), 1% penicillin/streptomycin, and 2 mM <span class="small-caps">l</span>-glutamine (glyB and glyBTII CHO cell lines) or complete RPMI 1640 supplemented with 10% FBS, 1% penicillin/streptomycin, and 2 mM <span class="small-caps">l</span>-glutamine [MIA PaCa-2 NTC, MIA PaCa-2 MFT knockdown (KD), and HPAC]. Prior to incubation with radiolabeled compounds, cells were cultured in complete FFRPMI for 48 hours. Two T150 flasks per treatment condition were seeded with 6 (CHO) or 8 (MIA PaCa-2/HPAC) million cells in FFRPMI medium supplemented with 60 <em>&#x000b5;</em>M adenosine and 10 <em>&#x000b5;</em>M thymidine (30 ml per T150 flask). Unlabeled MTX or <strong>AGF347</strong> (2 <em>&#x000b5;</em>M, final) and 9 <em>&#x000b5;</em>Ci of either [<sup>3</sup>H]MTX or [<sup>3</sup>H]<strong>AGF347</strong>, as appropriate, were added. For [<sup>3</sup>H]folic acid incubations, folate-depleted cells were seeded in complete <em>&#x003b1;</em>MEM or complete RPMI 1640 medium (containing 2.26 <em>&#x000b5;</em>M folic acid), to which 9 <em>&#x000b5;</em>Ci of [<sup>3</sup>H]folic acid was added. Cells were incubated with radiolabel for 48 hours; the cytosolic and mitochondrial fractions were separated by differential centrifugation (<a href="#B6" rid="B6" class=" bibr popnode">Clayton and Shadel, 2014</a>). In brief, cells were trypsinized, washed once with Dulbecco&#x02019;s phosphate-buffered saline, and resuspended in hypotonic resuspension buffer [10 mM NaCl, 1.5 mg MgCl<sub>2</sub>, 10 mM Tris (pH 7.5)] containing cOmplete Protease Inhibitor Cocktail (Sigma-Aldrich) for 15 minutes. Cells were lysed with 15 strokes of a B (i.e., &#x0201c;tight-fitting&#x0201d;) pestle in a 7-ml Dounce homogenizer. A 2.5&#x000d7; mannitol-sucrose (MS) buffer [5.5 mM mannitol, 175 mM sucrose, 12.5 mM Tris (pH 7.5), 2.5 mM EDTA] containing cOmplete Protease Inhibitor Cocktail (Sigma-Aldrich) was added to a final concentration of 1&#x000d7; MS, and an aliquot (i.e., &#x0201c;total&#x0201d; fraction containing both cytosol and mitochondria) was sampled for radioactivity measurement and protein assay (<a href="#B32" rid="B32" class=" bibr popnode">Lowry et al., 1951</a>). The homogenized cell suspension was centrifuged (3100 rpm, 5 minutes) at 4&#x000b0;C in a Jouan CR4i centrifuge (Thermo Fisher) to pellet nuclei and unbroken cells. After collecting the supernatant (contains mitochondria), nuclei and the unbroken cell pellets were resuspended in 1&#x000d7; MS, homogenized with five additional strokes, and centrifuged at 3100 rpm. The supernatant was pooled with the previous supernatant and centrifuged at 11,900 rpm at 4&#x000b0;C for 15 minutes in a Sorvall SS34 rotor (Thermo Fisher) to collect the mitochondria. The supernatant (i.e., cytosol fraction) was collected, and aliquots were assayed for radioactivity and protein. The mitochondrial pellet was washed once with 1&#x000d7; MS, centrifuged at 11,900 rpm for 15 minutes, and solubilized in 0.5 N NaOH, after which aliquots were assayed for radioactivity and proteins (i.e., mitochondrial fraction). To assess purities and yields of the cytosolic and mitochondrial fractions, parallel incubations were performed with no inhibitor or radiolabel, and cells were harvested for mitochondria and cytosol fractionation, as described earlier, and assays of lactate dehydrogenase (LDH; cytosolic marker) and succinate dehydrogenase (SDH; mitochondrial marker). LDH was assayed (<a href="#B53" rid="B53" class=" bibr popnode">Royer et al., 1977</a>) in sodium phosphate buffer (0.03 M, pH 7.4) with excess of sodium pyruvate (300 <em>&#x000b5;</em>M) and NADH (70 <em>&#x003bc;</em>M) by measuring the rate of decrease in absorbance at 340 nm. SDH was assayed (<a href="#B22" rid="B22" class=" bibr popnode">Kolaj-Robin et al., 2011</a>) in potassium phosphate buffer (10 mM, pH 7.5 with 1 mM potassium cyanide) with excess sodium succinate (20 mM) and 2,6-dichlorophenolindophenol by measuring the rate of decrease in absorbance at 600 nm.</p></div><div id="s11" class="sec"><p></p><h4 id="s11title" class="inline">Measurements of AGF347 Polyglutamylation. </h4><p class="p p-first-last">Synthesis of <strong>AGF347</strong> polyglutamates was assayed in the cytosolic and mitochondrial fractions (aforementioned) from MIA PaCa-2 NTC cells, as previously described (<a href="#B23" rid="B23" class=" bibr popnode">Kugel Desmoulin et al., 2011</a>) with modifications. In brief, the aforementioned protocol for subcellular fractionation was modified by addition of 18 <em>&#x000b5;</em>Ci of [<sup>3</sup>H]<strong>AGF347</strong> to each T150 flask (final concentration 2 <em>&#x000b5;</em>M). Following incubation (48 hours), the cytosolic and mitochondrial fractions were isolated, then boiled (10 minutes), cooled (4&#x000b0;C), and centrifuged (14,000 rpm) in a microcentrifuge (4&#x000b0;C for 15 minutes). The supernatant was fractionated on an Agilent Infinity II 1260 high performance liquid chromatography (HPLC) system (Agilent Technologies Inc., Woburn, MA) using a Waters 4-<em>&#x003bc;</em>m Nova-Pak C18 column (3.9 &#x000d7; 150 mm) with a Nova-Pak 4-<em>&#x003bc;</em>m C18 guard column (Waters Corporation, Milford, MA). A mobile phase of 100 mM sodium acetate, pH 5.5 (mobile phase A), and 100% acetonitrile (mobile phase B) was used; the gradient was 100% A from 0 to 5 minutes, followed by a linear increase from 100% A at 5 minutes to 75% A/25% B at 35 minutes. The flow rate was 1.6 ml/min. Fractions were collected every minute for the first 5 minutes, every 30 seconds for the next 5 minutes, and every 10 seconds thereafter. Radioactivity was measured with a scintillation counter, and the amounts of the individual polyglutamates were calculated from the percentage of total radioactivity in each peak and total pmol/mg [<sup>3</sup>H]<strong>AGF347</strong> in each compartment (mitochondria and cytosol). To confirm the identities of the peaks as <strong>AGF347</strong> polyglutamates, the MIA PaCa-2 cytosolic sample was treated overnight with a preparation of chicken pancreas conjugase (<a href="#B37" rid="B37" class=" bibr popnode">Matherly et al., 1985</a>) in 0.5 ml of 0.1 M sodium borate, pH 7.8, containing 10 mM 2-mercaptoethanol at 32&#x000b0;C to hydrolyze all polyglutamates to the <strong>AGF347</strong> monoglutamyl form. Samples were deproteinized by boiling (5 minutes), then reanalyzed by HPLC.</p></div><div id="s12" class="sec"><p></p><h4 id="s12title" class="inline">Determination of Oxygen Consumption Rate. </h4><p class="p p-first-last">Oxygen consumption rate (OCR) measurements were made using a Seahorse XFe24 extracellular flux analyzer (Agilent Technologies). HCT116 wild-type (WT) and SHMT2 KO cells were grown in complete folate-free, glycine-replete RPMI 1640 supplemented with 10% dialyzed FBS, 1% penicillin/streptomycin, 25 nM leucovorin, 2 mM <span class="small-caps">l</span>-glutamine, and adenosine (60 <em>&#x000b5;</em>M) and treated with <strong>AGF347</strong> (10 <em>&#x000b5;</em>M) or vehicle (DMSO) for 48 hours. Cells were then seeded into gelatin-coated XFe24 cell culture microplates in the same medium (containing drug) at a density of 130,000 cells per well (five replicate wells per condition) and allowed to adhere for 24 hours. OCRs were monitored at baseline and throughout sequential injections of oligomycin (1 <em>&#x003bc;</em>M), carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (1 <em>&#x003bc;</em>M), and rotenone/antimycin A (1 <em>&#x003bc;</em>M each). OCRs were normalized to cell numbers in each well by solubilizing cells with 0.5 N NaOH and assaying proteins by the Folin-phenol method (<a href="#B32" rid="B32" class=" bibr popnode">Lowry et al., 1951</a>).</p></div><div id="s13" class="sec"><p></p><h4 id="s13title" class="inline">Measurements of reduced glutathione and ROS. </h4><p class="p p-first-last">HCT116 (WT, SHMT1 KO, and SHMT2 KO), HPAC, and BxPC-3 cells (25,000 cells per well in a 96-well plate), and MIA PaCa-2 cells (40,000 cells per well) were seeded for the ROS assays. For the reduced glutathione (GSH) assays, 20,000 cells per well were seeded. Cells were incubated (24 hours) in complete FFRPMI supplemented with 10% dialyzed FBS, 1% penicillin/streptomycin, 25 nM leucovorin, and 2 mM <span class="small-caps">l</span>-glutamine overnight under normoxic conditions (21% O<sub>2</sub>, 5% CO<sub>2</sub>), at which time the medium was replaced with FFRPMI without glycine, supplemented with 10% dialyzed FBS, 1% penicillin/streptomycin, 2 mM <span class="small-caps">l</span>-glutamine, 25 nM leucovorin, and 60 <em>&#x000b5;</em>M adenosine. The cells were treated with 10 <em>&#x000b5;</em>M <strong>AGF347</strong> or an equivalent volume of vehicle (i.e., DMSO) for 24 hours under hypoxia (0.5% O<sub>2</sub>, 5% CO<sub>2</sub>) (<a href="#B68" rid="B68" class=" bibr popnode">Ye et al., 2014</a>) in a Biospherix hypoxia chamber (Biospherix, Parish, NY); for the ROS assays, parallel incubations (24 hours) were also performed in normoxic conditions (21% O<sub>2</sub>, 5% CO<sub>2</sub>). Cells were then processed for ROS measurements (catalog number K936; Biovision, Milpitas, CA) by the 2&#x02032;,7&#x02032;-dichlorodihydrofluorescein diacetate (H<sub>2</sub>DCFDA) assay and for GSH measurements (catalog number V6911; Promega, Madison, WI) by a GSH <em>S</em>-transferase&#x02013;based luminescence assay following the manufacturers&#x02019; protocols. To measure total glutathione pools&#x02014;both reduced (i.e., GSH) and oxidized [glutathione disulfide (GSSG)] forms&#x02014;cells were treated with 500 <em>&#x003bc;</em>M tris(2-carboxyethyl)phosphine to reduce GSSG to GSH just prior to GSH assay. For the ROS assays, a positive control (ROS inducer) was included in the ROS assay kit. For both ROS and GSH/GSSG levels, results were normalized to cell numbers in each well by solubilizing with 0.5 N NaOH and assaying proteins (<a href="#B32" rid="B32" class=" bibr popnode">Lowry et al., 1951</a>). For the GSH/GSSG assays, protein normalization was based on protein concentrations for identically treated plates that were incubated in parallel with the experimental plate.</p></div><div id="s14" class="sec sec-last"><p></p><h4 id="s14title" class="inline">Statistics. </h4><p class="p p-first">Sample sizes were predetermined before each experiment. All statistical comparisons were performed using a two-tailed unpaired <em>t</em> test corrected for unequal variance after data were transformed to meet normality assumptions, and no <em>P</em> value adjustments were made for multiple comparisons. A log<sub>10</sub> transformation was used for data with positive values, and when data included zero values, a square root transformation was used instead. For depicting data in plots, all data were summarized with mean values and S.D. using data without transformation. Geometric mean values and their associated 95% confidence intervals were used to summarize IC<sub>50</sub> and transport kinetics results using data without transformation in <a href="/pmc/articles/PMC6877291/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Tables 1</span></a> and <a href="/pmc/articles/PMC6877291/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and2.</span></span><span>2</span></a>. Experiments that were exploratory in character were descriptively summarized without statistical comparisons.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>TABLE 1</h3><!--caption a7--><div class="caption"><p>IC<sub>50</sub> values for antiproliferative activities toward HCT116 colon cancer and pancreatic cancer cell line panel</p><p>Proliferation inhibition assays were performed using the HCT116 (colon cancer), MIA PaCa-2, HPAC, BxPC-3, CFPAC, and AsPC-1 (all PaC), and HPNE cell lines. Results are shown as geometric mean IC<sub>50</sub> values (with 95% confidence interval), corresponding to the concentrations that inhibit growth by 50% relative to vehicle-treated control cells, from three biologic replicates.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1">Compound</th><th align="center" colspan="7" rowspan="1">Proliferation Inhibition (IC<sub>50</sub>)</th></tr><tr><th align="center" rowspan="1" colspan="1">HCT116</th><th align="center" rowspan="1" colspan="1">MIA PaCa-2</th><th align="center" rowspan="1" colspan="1">HPAC</th><th align="center" rowspan="1" colspan="1">BxPC-3</th><th align="center" rowspan="1" colspan="1">CFPAC</th><th align="center" rowspan="1" colspan="1">AsPC-1</th><th align="center" rowspan="1" colspan="1">HPNE</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td><td align="center" rowspan="1" colspan="1"><em>nM</em></td></tr><tr><td rowspan="1" colspan="1"><strong>AGF291</strong></td><td align="center" rowspan="1" colspan="1">2121 (1609&#x02013;2795)</td><td align="center" rowspan="1" colspan="1">2294 (2110&#x02013;2493)</td><td align="center" rowspan="1" colspan="1">309 (268&#x02013;355)</td><td align="center" rowspan="1" colspan="1">251 (229&#x02013;274)</td><td align="center" rowspan="1" colspan="1">419 (304&#x02013;578)</td><td align="center" rowspan="1" colspan="1">284 (261&#x02013;310)</td><td align="center" rowspan="1" colspan="1">&#x0003e;5000</td></tr><tr><td rowspan="1" colspan="1"><strong>AGF320</strong></td><td align="center" rowspan="1" colspan="1">742 (486&#x02013;1134)</td><td align="center" rowspan="1" colspan="1">1540 (1503&#x02013;1578)</td><td align="center" rowspan="1" colspan="1">739 (606&#x02013;901)</td><td align="center" rowspan="1" colspan="1">632 (425&#x02013;940)</td><td align="center" rowspan="1" colspan="1">1912 (1621&#x02013;2256)</td><td align="center" rowspan="1" colspan="1">436 (419&#x02013;453)</td><td align="center" rowspan="1" colspan="1">&#x0003e;5000</td></tr><tr><td rowspan="1" colspan="1"><strong>AGF347</strong></td><td align="center" rowspan="1" colspan="1">347 (301&#x02013;400)</td><td align="center" rowspan="1" colspan="1">639 (542&#x02013;753)</td><td align="center" rowspan="1" colspan="1">194 (157&#x02013;239)</td><td align="center" rowspan="1" colspan="1">80 (72&#x02013;89)</td><td align="center" rowspan="1" colspan="1">317 (284&#x02013;354)</td><td align="center" rowspan="1" colspan="1">203 (122&#x02013;337)</td><td align="center" rowspan="1" colspan="1">&#x0003e;5000</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140247880976736"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/table/T1/?report=objectonly">Open in a separate window</a></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>TABLE 2</h3><!--caption a7--><div class="caption"><p>Transport kinetics for 6-substituted pyrrolo[3,2-<em>d</em>]pyrimidine analogs compared with MTX, PMX, and <strong>AGF94</strong></p><p>Transport assays were performed using engineered R2/PCFT4 (expresses PCFT only) and R1-11 RFC2 (expresses RFC only) cells. For determinations of K<sub>m</sub> and V<sub>max</sub> values by Lineweaver-Burk analysis, concentrations of [<sup>3</sup>H]<strong>AGF347</strong> or [<sup>3</sup>H]MTX were from 0.02 to 0.5 <em>&#x003bc;</em>M for R2/PCFT4 (at pH 5.5) and from 0.25 to 5 <em>&#x000b5;</em>M for R1-11 RFC2 (at pH 7.2). K<sub>i</sub> values for each of the drugs were determined by Dixon analysis over a range of concentrations of nonradioactive competitor from 0 to 500 nM (for R2/PCFT4 at pH 5.5) or 0 to 1 <em>&#x000b5;</em>M (for R1-11 RFC2 at pH 7.2) and 0.5 <em>&#x000b5;</em>M [<sup>3</sup>H]MTX. Results are presented as geometric mean values (with 95% confidence intervals) from three biologic replicates. Pairwise statistical comparisons were performed against MTX (K<sub>m</sub> and V<sub>max</sub>) and PMX (K<sub>i</sub>) using two-sided, unpaired <em>t</em> test.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1">Substrate</th><th align="center" colspan="4" rowspan="1">RFC (R1-11 RFC2), pH 7.2</th><th align="center" colspan="4" rowspan="1">PCFT (R2/PCFT4), pH 5.5</th></tr><tr><th align="center" rowspan="1" colspan="1">K<sub>m</sub></th><th align="center" rowspan="1" colspan="1">V<sub>max</sub></th><th align="center" rowspan="1" colspan="1">V<sub>max</sub>/K<sub>m</sub></th><th align="center" rowspan="1" colspan="1">K<sub>i</sub></th><th align="center" rowspan="1" colspan="1">K<sub>m</sub></th><th align="center" rowspan="1" colspan="1">V<sub>max</sub></th><th align="center" rowspan="1" colspan="1">V<sub>max</sub>/K<sub>m</sub></th><th align="center" rowspan="1" colspan="1">K<sub>i</sub></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>&#x000b5;M</em></td><td align="center" rowspan="1" colspan="1"><em>pmol/mg per minute</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>&#x000b5;M</em></td><td align="center" rowspan="1" colspan="1"><em>&#x000b5;M</em></td><td align="center" rowspan="1" colspan="1"><em>pmol/mg per minute</em></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>&#x000b5;M</em></td></tr><tr><td rowspan="1" colspan="1">MTX</td><td align="center" rowspan="1" colspan="1">0.609 (0.597&#x02013;0.622)</td><td align="center" rowspan="1" colspan="1">80 (44&#x02013;144)</td><td align="center" rowspan="1" colspan="1">118 (110&#x02013;126)</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.329 (0.245&#x02013;0.441)</td><td align="center" rowspan="1" colspan="1">404 (184&#x02013;888)</td><td align="center" rowspan="1" colspan="1">1230 (687&#x02013;2204)</td><td align="center" rowspan="1" colspan="1">ND</td></tr><tr><td rowspan="1" colspan="1">PMX</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.583 (0.513&#x02013;0.663)</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.056 (0.054&#x02013;0.058)</td></tr><tr><td rowspan="1" colspan="1"><strong>AGF94</strong></td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">1.614<sup>***</sup> (1.423&#x02013;1.830)</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.070<sup>ns</sup> (0.044&#x02013;0.111)</td></tr><tr><td rowspan="1" colspan="1"><strong>AGF291</strong></td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.276<sup>**</sup> (0.225&#x02013;0.338)</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.163<sup>#</sup> (0.096&#x02013;0.275)</td></tr><tr><td rowspan="1" colspan="1"><strong>AGF320</strong></td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.200<sup>*</sup> (0.148&#x02013;0.272)</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">ND</td><td align="center" rowspan="1" colspan="1">0.142<sup>*</sup> (0.097&#x02013;0.209)</td></tr><tr><td rowspan="1" colspan="1"><strong>AGF347</strong></td><td align="center" rowspan="1" colspan="1">0.388<sup>ns</sup> (0.280&#x02013;0.536)</td><td align="center" rowspan="1" colspan="1">72<sup>ns</sup> (68&#x02013;75)</td><td align="center" rowspan="1" colspan="1">205 (156&#x02013;270)</td><td align="center" rowspan="1" colspan="1">0.247<sup>*</sup> (0.186&#x02013;0.327)</td><td align="center" rowspan="1" colspan="1">0.057<sup>*</sup> (0.038&#x02013;0.086)</td><td align="center" rowspan="1" colspan="1">184 (129&#x02013;263)</td><td align="center" rowspan="1" colspan="1">3227 (1499&#x02013;6945)</td><td align="center" rowspan="1" colspan="1">0.070<sup>***</sup> (0.068&#x02013;0.073)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140247888560272"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.r.b.b.l.d.d.a"><p class="p p-first-last">ND, not determined; ns, &#x0201c;no significant difference&#x0201d; when comparing parameters from MTX and <strong>AGF347</strong>.</p></div><div id="tfn1"><sup>#</sup><em>P</em> &#x0003c; 0.1; *<em>P</em> &#x0003c; 0.05; **<em>P</em> &#x0003c; 0.01; ***<em>P</em> &#x0003c; 0.001.</div></div></div></div></div></div><div id="s15" class="tsec sec"><h2 class="head no_bottom_margin" id="s15title">Results</h2><div id="s16" class="sec sec-first"><h3 id="s16title">Demonstration of Efficacy and Mechanism in a Pancreatic Cancer Cell Line Panel</h3><p class="p p-first">Our earlier study (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) established in vitro antitumor efficacies of our pyrrolo[3,2-<em>d</em>]pyrimidine compounds <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong> toward H460 lung cancer, HCT116 colon cancer, and MIA PaCa-2 PaC cell line models. With the demonstrated activity of <strong>AGF347</strong> in vivo against MIA PaCa-2 PaC xenografts (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>), we extended our studies to include four additional PaC cell lines (HPAC, BxPC-3, CFPAC-1, AsPC-1) characterized by expression of RFC and PCFT, but not folate receptor <em>&#x003b1;</em> (<a href="http://molpharm.aspetjournals.org/lookup/suppl/doi:10.1124/mol.119.117937/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplemental Fig. 1</a>). Proliferation results with the PaC cell lines were compared with those for HPNE cells (<a href="#B27" rid="B27" class=" bibr popnode">Lee et al., 2003</a>). For HPAC, BxPC-3, CFPAC-1, and AsPC-1 cells, the compounds showed increased (&#x0223c;4- to 9-fold) inhibitory activity relative to MIA PaCa-2 cells (<a href="/pmc/articles/PMC6877291/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). <strong>AGF347</strong> (<a href="/pmc/articles/PMC6877291/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>) was consistently the most active of the series, with the lowest IC<sub>50</sub> values recorded in the HPAC (194 nM) and BxPC-3 (80 nM) cells. In HPNE cells, the pyrrolo[3,2-<em>d</em>]pyrimidine analogs were inactive up to 5000 nM (<a href="/pmc/articles/PMC6877291/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>).</p><p class="p p-last">To confirm the targeted pathways for <strong>AGF347</strong> in HPAC and BxPC-3 cells, we performed &#x0201c;rescue&#x0201d; experiments in <em>glycine- and nucleoside-free</em> media (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) to assess the protective effects of supplemented glycine (130 <em>&#x000b5;</em>M) and/or adenosine (60 <em>&#x000b5;</em>M) (<a href="/pmc/articles/PMC6877291/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>). Neither glycine nor adenosine alone rescued cell proliferation from the effects of <strong>AGF347</strong>, although the combination effected complete rescue. These results are entirely consistent with our earlier studies (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) that established the inhibition of mitochondrial C1 metabolism and de novo purine biosynthesis by <strong>AGF347</strong> in MIA PaCa-2 cells.</p></div><div id="s17" class="sec"><h3 id="s17title">Determination of Plasma Membrane Transport of AGF347</h3><p class="p p-first">Previous studies of antiproliferative activities of <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong> toward isogenic CHO cells engineered to individually express RFC or PCFT suggested cellular uptake of this series by these facilitative transporters (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). To directly measure transport of <strong>AGF347</strong> by these systems, we performed transport assays with [<sup>3</sup>H]<strong>AGF347</strong> in cell lines engineered to individually express RFC [R1-11 RFC2 HeLa (<a href="#B63" rid="B63" class=" bibr popnode">Wang et al., 2015</a>)] or PCFT [R2/PCFT4 CHO (<a href="#B9" rid="B9" class=" bibr popnode">Deng et al., 2009</a>)]. Transport of [<sup>3</sup>H]<strong>AGF347</strong> (0.5 <em>&#x000b5;</em>M) was measured over 5 minutes at pH 7.2 (RFC) or pH 5.5 (PCFT) (approximating the respective pH optima) at 37&#x000b0;C, and results were compared with those with [<sup>3</sup>H]MTX. For both [<sup>3</sup>H]MTX and [<sup>3</sup>H]<strong>AGF347</strong>, transport was substantial for both PCFT and RFC. Transport was effectively abolished (&#x02265;90%) by excess unlabeled substrates with specificity for PCFT [<strong>AGF94</strong> (<a href="#B62" rid="B62" class=" bibr popnode">Wang et al., 2011</a>)] and RFC [PT523 (<a href="#B51" rid="B51" class=" bibr popnode">Rosowsky, 1999</a>)] (<a href="/pmc/articles/PMC6877291/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3, A and B</span></a>). Transport kinetics were determined for [<sup>3</sup>H]MTX and [<sup>3</sup>H]<strong>AGF347</strong>. For both PCFT and RFC, the differences in V<sub>max</sub> values for <strong>AGF347</strong> versus MTX were not significant. The differences in K<sub>m</sub> values for MTX versus <strong>AGF347</strong> with RFC were also insignificant, whereas <strong>AGF347</strong> had a significant 5.8-fold decreased K<sub>m</sub> for PCFT (0.057 vs. 0.329 <em>&#x000b5;</em>M, respectively) compared with MTX (<a href="/pmc/articles/PMC6877291/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC6877291/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247871982080"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247871982080"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Fig. 3.</a></div><!--caption a7--><div class="caption"><p>Plasma membrane uptake of <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong>. (A and B) Inhibition of [<sup>3</sup>H]MTX and [<sup>3</sup>H]<strong>AGF347</strong> uptake (both at 0.5 <em>&#x000b5;</em>M) in RFC-expressing R1-11 RFC2 HeLa cells at pH 7.2 (A) and PCFT-expressing R2/PCFT4 CHO cells at pH 5.5 (B). <strong>AGF94</strong> and PT523 treatments (both at 10 <em>&#x000b5;</em>M) were used as PCFT- and RFC-specific inhibitor controls, respectively. Results (mean values &#x000b1; S.D.) reflect three biologic replicates and are expressed as the fraction of [<sup>3</sup>H]MTX uptake relative to vehicle (i.e., DMSO)-treated cells. (C&#x02013;E) Uptake of [<sup>3</sup>H]<strong>AGF347</strong> in HCT116 WT (C) and PaC cells at pH 5.5 (C), pH 7.2 (D), and pH 6.8 (E), without additions or in the presence of 10 <em>&#x000b5;</em>M <strong>AGF94</strong> and/or PT523. Results (mean values &#x000b1; S.D.) reflect three biologic replicates and are expressed as pmol [<sup>3</sup>H]substrate per mg protein. <sup>#</sup><em>P</em> &#x0003c; 0.10; *<em>P</em> &#x0003c; 0.05; **<em>P</em> &#x0003c; 0.01; ***<em>P</em> &#x0003c; 0.001. ns, not significant. Pairwise statistical comparisons were performed by two-sided unpaired <em>t</em> tests against R1-11 RFC2 (A), R2/PCFT4 (B), and none (C&#x02013;E), unless otherwise specified by lines indicating pairs to be compared. Experimental details are in <a href="#s2" rid="s2" class=" sec"><em>Materials and Methods</em></a>.</p></div></div></div><p>Transporter binding for the pyrrolo[3,2-<em>d</em>]pyrimidine analogs <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong> (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) was further assessed by calculating K<sub>i</sub> values by Dixon analysis with [<sup>3</sup>H]MTX in the PCFT and RFC engineered cell lines, using the calculated K<sub>m</sub> and V<sub>max</sub> values for [<sup>3</sup>H]MTX. The results were compared with those calculated for <strong>AGF94</strong> and PMX (<a href="/pmc/articles/PMC6877291/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). By these analyses, K<sub>i</sub> values for <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong> for RFC were essentially equivalent (range of 0.200&#x02013;0.274 <em>&#x000b5;</em>M) and were 2- to 3-fold lower than that for PMX (0.583 <em>&#x000b5;</em>M). For PCFT, the K<sub>i</sub> for <strong>AGF347</strong> (0.070 <em>&#x000b5;</em>M) was 2- to 2.5-fold lower than those for <strong>AGF291</strong> (0.163 <em>&#x000b5;</em>M) and <strong>AGF320</strong> (0.142 <em>&#x000b5;</em>M) and was equivalent to that for <strong>AGF94</strong> (0.070 <em>&#x000b5;</em>M); the K<sub>i</sub> value for <strong>AGF347</strong> was similar to that for PMX (0.056 <em>&#x000b5;</em>M), among the best PCFT substrates (<a href="#B4" rid="B4" class=" bibr popnode">Chattopadhyay <em>et al.</em>, 2007</a>; <a href="#B60" rid="B60" class=" bibr popnode">Unal <em>et al.</em>, 2008</a>; <a href="#B62" rid="B62" class=" bibr popnode">Wang <em>et al.</em>, 2011</a>).</p><p>To extend these transport analyses to the assorted PaC cell lines, we measured uptake of [<sup>3</sup>H]<strong>AGF347</strong> at both pH 5.5 and pH 7.2 in the presence or absence of excess (10 <em>&#x000b5;</em>M) unlabeled <strong>AGF94</strong> and/or PT523 to gauge the relative contributions of PCFT and RFC, respectively, to [<sup>3</sup>H]<strong>AGF347</strong> uptake. Our experiments revealed substantial uptake of [<sup>3</sup>H]<strong>AGF347</strong> by PCFT at pH 5.5 and by RFC at pH 7.2 (<a href="/pmc/articles/PMC6877291/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3, C and D</span></a>). At pH 5.5, PCFT uptake was blocked by <strong>AGF94</strong>, albeit incompletely (&#x0223c;30%&#x02013;90%); this suggests a contribution from a non-PCFT transporter in addition to PCFT. Analogous results were recorded at pH 7.2, although transport was blocked (&#x0223c;65%&#x02013;85%) by PT523, demonstrating principal involvement of RFC.</p><p class="p p-last">Experiments with the PaC cell lines were extended to pH 6.8, approximating the pH of the tumor microenvironment (<a href="#B56" rid="B56" class=" bibr popnode">Stubbs et al., 2000</a>). At pH 6.8 (<a href="/pmc/articles/PMC6877291/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3E</span></a>), uptake of [<sup>3</sup>H]<strong>AGF347</strong> was mediated by both PCFT and RFC such that the transport inhibition by both <strong>AGF94</strong> and PT523 together was substantial and ranged from &#x0223c;70% to 90%. Uptake of [<sup>3</sup>H]<strong>AGF347</strong> by RFC predominated at pH 6.8, as reflected in the generally greater decrease in net uptake for samples treated with PT523 compared with those treated with <strong>AGF94</strong>. Collectively, these studies establish important roles for both RFC and PCFT in the uptake of <strong>AGF347</strong> by PaC cells.</p></div><div id="s18" class="sec"><h3 id="s18title">Subcellular Compartmentation of AGF347 and Metabolism to Polyglutamates</h3><p class="p p-first">Implicit to targeting of mitochondrial C1 metabolism by our pyrrolo[3,2-<em>d</em>]pyrimidine inhibitors (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) is their uptake and accumulation in the mitochondria. Further, as these molecules are negatively charged, they likely require facilitated uptake into mitochondria, possibly mediated by the MFT, the only known transporter of folates into the mitochondrial matrix (<a href="#B39" rid="B39" class=" bibr popnode">McCarthy et al., 2004</a>; <a href="#B25" rid="B25" class=" bibr popnode">Lawrence et al., 2011</a>).</p><p>We assessed mitochondrial accumulation of [<sup>3</sup>H]<strong>AGF347</strong> by MIA PaCa-2 cells in comparison with [<sup>3</sup>H]folic acid and [<sup>3</sup>H]MTX. To determine whether MFT contributes to mitochondrial uptake of [<sup>3</sup>H]<strong>AGF347</strong>, we transfected human MFT (myc-His6&#x02013;tagged) into MFT-null glyB CHO cells (<a href="#B39" rid="B39" class=" bibr popnode">McCarthy et al., 2004</a>) to generate the glyBTII cell line (<a href="http://molpharm.aspetjournals.org/lookup/suppl/doi:10.1124/mol.119.117937/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplemental Fig. 2A</a> shows a Western blot of glyB and glyBTII cell extracts probed with Myc antibody, confirming ectopic MFT-myc-His6 expression). For MIA PaCa-2 cells, we generated NTC and MFT short hairpin RNA KD (MFT KD) cells to assess the transport role of MFT in a human tumor model (<a href="http://molpharm.aspetjournals.org/lookup/suppl/doi:10.1124/mol.119.117937/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplemental Fig. 2B</a>). We also measured mitochondrial uptake of [<sup>3</sup>H]<strong>AGF347</strong> and [<sup>3</sup>H]MTX in HPAC cells.</p><p>The cell lines were cultured for 48 hours, after which [<sup>3</sup>H]folic acid (2.26 <em>&#x000b5;</em>M), [<sup>3</sup>H]MTX (2 <em>&#x000b5;</em>M), or [<sup>3</sup>H]<strong>AGF347 (</strong>2 <em>&#x000b5;</em>M) was added for an additional 48 hours [in the presence of 60 <em>&#x000b5;</em>M adenosine and 10 <em>&#x000b5;</em>M thymidine to abrogate any potential cytotoxic drug effects (<a href="#B8" rid="B8" class=" bibr popnode">Deng et al., 2008</a>; <a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>)]. Mitochondrial and cytosolic fractions were isolated by differential centrifugation (<a href="#B6" rid="B6" class=" bibr popnode">Clayton and Shadel, 2014</a>), with the radioactivity in each fraction quantified (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4, A&#x02013;C</span></a>) and normalized to protein (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4, D&#x02013;F</span></a>). LDH (<a href="#B30" rid="B30" class=" bibr popnode">Lin et al., 1993</a>) and SDH catalytic activities (<a href="#B45" rid="B45" class=" bibr popnode">Munujos et al., 1993</a>) were used as measures of purity and cross-contamination between the cytosolic and mitochondrial fractions, respectively (<a href="http://molpharm.aspetjournals.org/lookup/suppl/doi:10.1124/mol.119.117937/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplemental Table 1</a>). Whereas the mitochondrial fractions were highly pure (&#x0003c;5% cytosolic contamination), cytosolic fractions were contaminated with lysed mitochondria.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247932538016"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247932538016"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Fig. 4.</a></div><!--caption a7--><div class="caption"><p>Subcellular compartmentation of <strong>AGF347</strong> relative to folic acid and MTX. (A&#x02013;F) Relative distributions of [<sup>3</sup>H]folic acid (2.26 <em>&#x000b5;</em>M) (A), [<sup>3</sup>H]MTX (2 <em>&#x000b5;</em>M) (B), and [<sup>3</sup>H]<strong>AGF347</strong> (2 <em>&#x000b5;</em>M) (C), as well as total cellular (D) and compartment-specific accumulations in the cytosol (E) and mitochondria (F) of glyB (MFT-null) and glyBTII (human MFT transfected) CHO cells and MIA PaCa-2 NTC (MFT WT) and MIA PaCa-2 MFT KD (MFT KD) PaC cells. Results (mean values &#x000b1; S.D.) represent three biologic replicates and are expressed as a percentage (A&#x02013;C) or pmol [<sup>3</sup>H]substrate per mg protein in each cellular fraction (mitochondrial and cytosol) (D&#x02013;F). (G&#x02013;I) HPLC analysis of [<sup>3</sup>H]<strong>AGF347</strong> polyglutamyl derivatives in the cytosol (G) and mitochondria (H) of MIA PaCa-2 cells, along with a conjugase-treated aliquot of the cytosol (I). Results are expressed as counts per minute (CPM) eluted in a given time fraction (see <a href="#s2" rid="s2" class=" sec"><em>Materials and Methods</em></a>) and are representative of two biologic replicates. <sup>#</sup><em>P</em> &#x0003c; 0.10; *<em>P</em> &#x0003c; 0.05; **<em>P</em> &#x0003c; 0.01; ***<em>P</em> &#x0003c; 0.001. ns, not significant. Pairwise statistical comparisons were performed by two-sided unpaired <em>t</em> tests, and each line indicates a pair to be compared in (D)&#x02013;(F).</p></div></div></div><p>Substantial uptake of [<sup>3</sup>H]folic acid and [<sup>3</sup>H]<strong>AGF347</strong> was detected in both cytosolic and mitochondrial fractions of the glyBTII CHO and MIA PaCa-2 NTC sublines, with the mitochondrial fraction comprising 20%&#x02013;33% of the total accumulated [<sup>3</sup>H]folic acid and 14%&#x02013;16% of the total [<sup>3</sup>H]<strong>AGF347</strong> (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4, A&#x02013;C</span></a>) in cells. Cytosolic [<sup>3</sup>H]MTX accumulations were modest, and there were disproportionately low levels of [<sup>3</sup>H]MTX in mitochondria as previously reported (<a href="#B30" rid="B30" class=" bibr popnode">Lin et al., 1993</a>). Analogous results were obtained for HPAC cells (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4, B and C</span></a>). Thus, [<sup>3</sup>H]<strong>AGF347</strong> accumulates significantly in the mitochondria.</p><p>Mitochondrial [<sup>3</sup>H]folic acid accumulations significantly decreased in the MIA PaCa-2 MFT KD (&#x0223c;50%) and glyB (MFT-null) (&#x0223c;90%) cell lines compared with their MFT-functional counterparts (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4F</span></a>); this is consistent with MFT-mediated uptake of [<sup>3</sup>H]folic acid metabolites (<a href="#B39" rid="B39" class=" bibr popnode">McCarthy et al., 2004</a>). Although the mitochondrial accumulation of [<sup>3</sup>H]<strong>AGF347</strong> was likewise decreased (&#x0223c;35%) in glyB cells, compared with glyBTII cells, the decrease was less than the corresponding decrease in mitochondrial accumulation of [<sup>3</sup>H]folic acid between the same two cell lines. Further, there was no difference in the mitochondrial uptake of [<sup>3</sup>H]<strong>AGF347</strong> between the MIA PaCa-2 NTC and MFT KD sublines. Collectively, these results indicate that mitochondrial accumulation of [<sup>3</sup>H]<strong>AGF347</strong> is at least partially mediated by MFT.</p><p class="p">As FPGS is expressed as cytosolic and mitochondrial-specific isoforms, and polyglutamate folate cofactors are detected in both compartments (<a href="#B26" rid="B26" class=" bibr popnode">Lawrence et al., 2014</a>), we assessed whether [<sup>3</sup>H]<strong>AGF347</strong> polyglutamates could be identified in the cytosolic and mitochondrial fractions. The cytosolic and mitochondrial fractions from MIA PaCa-2 NTC cells incubated with [<sup>3</sup>H]<strong>AGF347</strong> were fractionated by HPLC for detection of [<sup>3</sup>H]<strong>AGF347</strong> polyglutamates and unmetabolized [<sup>3</sup>H]<strong>AGF347</strong>. In addition to the parent monoglutamyl [<sup>3</sup>H]<strong>AGF347</strong>, at least six metabolites (PG<sub>2&#x02013;7</sub>) were resolved in the cytosolic extract (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4G</span></a>), and three metabolites (labeled PG<sub>5&#x02013;7</sub> based on the elution times for the cytosolic extract) were detected in the corresponding mitochondrial extract (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4H</span></a>). To confirm identities of the peaks as polyglutamyl metabolites of [<sup>3</sup>H]<strong>AGF347</strong>, aliquots of the MIA PaCa-2 NTC cytosolic fraction were treated with chicken pancreas conjugase (<a href="#B23" rid="B23" class=" bibr popnode">Kugel Desmoulin et al., 2011</a>). The early-eluting metabolites quantitatively (&#x0003e;95%) reverted to parent [<sup>3</sup>H]<strong>AGF347</strong> (<a href="/pmc/articles/PMC6877291/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4I</span></a>), confirming that these radiolabeled metabolites were polyglutamyl forms of [<sup>3</sup>H]<strong>AGF347</strong>. These results establish near-complete metabolism to [<sup>3</sup>H]<strong>AGF347</strong> polyglutamates in both the cytosol and mitochondria of MIA PaCa-2 cells (<a href="/pmc/articles/PMC6877291/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>), suggesting that <strong>AGF347</strong> is an excellent substrate for FPGS in both compartments. In both the cytosol and the mitochondria, the pentaglutamyl and hexaglutamyl forms predominated.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T3"><h3>TABLE 3</h3><!--caption a7--><div class="caption"><p>Subcellular <strong>AGF347</strong> metabolite distributions in MIA PaCa-2 cells</p><p>MIA PaCa-2 NTC cells were incubated with 2 <em>&#x000b5;</em>M [<sup>3</sup>H]<strong>AGF347</strong> for 48 hours in the presence of adenosine (60 <em>&#x000b5;</em>M) and glycine (130 <em>&#x000b5;</em>M). Cytosolic and mitochondrial cellular fractions were isolated by differential centrifugation, and parent (PG<sub>1</sub>) and polyglutamyl (PG<sub>2</sub>&#x02013;PG<sub>7</sub>) forms were fractionated by reverse-phase HPLC and quantified. Results are expressed in units of pmol/mg protein as the average &#x000b1; range for biologic duplicate experiments and as the percentage of the total <strong>AGF347</strong> forms in each cellular compartment (cytosol and mitochondria).</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1">AGF347 Form</th><th align="center" colspan="2" rowspan="1">AGF347 Metabolite</th></tr><tr><th align="center" rowspan="1" colspan="1">Cytosol</th><th align="center" rowspan="1" colspan="1">Mitochondria</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><em>pmol/mg (%)</em></td><td align="center" rowspan="1" colspan="1"><em>pmol/mg (%)</em></td></tr><tr><td rowspan="1" colspan="1">PG<sub>7</sub></td><td align="center" rowspan="1" colspan="1">12.87 &#x000b1; 3.52 (6.42)</td><td align="center" rowspan="1" colspan="1">36.65 &#x000b1; 4.03 (14.28)</td></tr><tr><td rowspan="1" colspan="1">PG<sub>6</sub></td><td align="center" rowspan="1" colspan="1">68.03 &#x000b1; 0.37 (33.94)</td><td align="center" rowspan="1" colspan="1">115.53 &#x000b1; 6.48 (45.01)</td></tr><tr><td rowspan="1" colspan="1">PG<sub>5</sub></td><td align="center" rowspan="1" colspan="1">88.30 + 2.00 (44.05)</td><td align="center" rowspan="1" colspan="1">71.26 &#x000b1; 5.17 (27.76)</td></tr><tr><td rowspan="1" colspan="1">PG<sub>4</sub></td><td align="center" rowspan="1" colspan="1">14.31 &#x000b1; 2.08 (7.41)</td><td align="center" rowspan="1" colspan="1">12.59+/2.42 (4.90)</td></tr><tr><td rowspan="1" colspan="1">PG<sub>3</sub></td><td align="center" rowspan="1" colspan="1">7.45 &#x000b1; 0.76 (3.72)</td><td align="center" rowspan="1" colspan="1">8.91 &#x000b1; 1.28 (3.47)</td></tr><tr><td rowspan="1" colspan="1">PG<sub>2</sub></td><td align="center" rowspan="1" colspan="1">4.50 &#x000b1; 0.40 (2.24)</td><td align="center" rowspan="1" colspan="1">4.49 &#x000b1; 1.95 (1.75)</td></tr><tr><td rowspan="1" colspan="1">PG<sub>1</sub> (<strong>AGF347</strong>)</td><td align="center" rowspan="1" colspan="1">4.00 + 0.89 (2.49)</td><td align="center" rowspan="1" colspan="1">7.52 &#x000b1; 2.43 (2.93)</td></tr><tr><td rowspan="1" colspan="1">Total <strong>AGF347</strong> forms</td><td align="center" rowspan="1" colspan="1">200.45</td><td align="center" rowspan="1" colspan="1">256.69</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140247935365680"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/table/T3/?report=objectonly">Open in a separate window</a></div></div></div><div id="s19" class="sec sec-last"><h3 id="s19title">Downstream Effects of Targeting SHMT2 and De Novo Purine Biosynthesis by AGF347</h3><p class="p p-first">We previously reported that the pyrrolo[3,2-<em>d</em>]pyrimidine compounds <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong> all targeted SHMT2 in the mitochondria, and SHMT1 and the purine biosynthetic enzymes GARFTase and/or AICARFTase in the cytosol (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). Inhibition of de novo purine biosynthesis was accompanied by elevation of AICA ribonucleotide and suppression of cellular purine nucleotide pools (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). We considered the possibility that downstream effects of these inhibitions could significantly contribute to the antitumor efficacy of <strong>AGF347</strong> and related compounds in vitro and in vivo (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>), including those involving: 1) mTOR signaling (<a href="#B49" rid="B49" class=" bibr popnode">Racanelli et al., 2009</a>; <a href="#B52" rid="B52" class=" bibr popnode">Rothbart et al., 2010</a>), 2) mitochondrial respiration (<a href="#B42" rid="B42" class=" bibr popnode">Minton et al., 2018</a>; <a href="#B44" rid="B44" class=" bibr popnode">Morscher et al., 2018</a>), and 3) elevated ROS due to decreased glycine synthesis and GSH pools (<a href="#B68" rid="B68" class=" bibr popnode">Ye et al., 2014</a>).</p><div id="s20" class="sec"><p></p><h4 id="s20title" class="inline">Inhibition of mTOR Signaling. </h4><p class="p p-first">Both elevated AICA ribonucleotide (via activation of AMPK) (<a href="#B49" rid="B49" class=" bibr popnode">Racanelli et al., 2009</a>; <a href="#B52" rid="B52" class=" bibr popnode">Rothbart et al., 2010</a>) and decreased purines (<a href="#B19" rid="B19" class=" bibr popnode">Hoxhaj et al., 2017</a>) can suppress the prosurvival mTOR pathway (<a href="#B29" rid="B29" class=" bibr popnode">Lim et al., 2015</a>). As Ras-ERK exhibits &#x0201c;cross-talk&#x0201d; with AMPK-mTOR signaling (<a href="#B41" rid="B41" class=" bibr popnode">Mendoza et al., 2011</a>; <a href="#B35" rid="B35" class=" bibr popnode">Mann et al., 2016</a>; <a href="#B28" rid="B28" class=" bibr popnode">Liang et al., 2019</a>), we assessed the impact of <strong>AGF347</strong> treatment (10 <em>&#x003bc;</em>M, 48 hours) on both BxPC-3 (KRAS WT) and HPAC (KRAS mutant) PaC cell lines by analyzing changes in phosphorylation of AMPK (P-AMPK) and the mTOR effectors p70- and p85-S6K1 (<a href="#B34" rid="B34" class=" bibr popnode">Magnuson et al., 2012</a>) by Western blotting. Treatment with AICAR (1 mM) elevates AICA ribonucleotide levels and was used as a positive control (<a href="#B43" rid="B43" class=" bibr popnode">Mitchell-Ryan et al., 2013</a>). Results are shown in <a href="/pmc/articles/PMC6877291/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC6877291/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247898536256"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f5.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f5.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247898536256"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Fig. 5.</a></div><!--caption a7--><div class="caption"><p>Inhibition of mTOR signaling by <strong>AGF291</strong>, <strong>AGF320</strong>, and <strong>AGF347</strong>. Activation of AMPK and suppression of mTOR signaling via S6K1 (mTOR effector, p85 and p70 isoforms) in vehicle-, AICAR-, or drug-treated KRAS WT BxPC-3 and KRAS mutant HPAC cells. The cell lines were analyzed on the same gel with a single marker. AMPK activation is reflected in the hyperphosphorylation (P-AMPK) and S6K1 suppression is reflected in the hypophosphorylation of p85-S6K1 and p70-S6K1 (P-p85-S6K1 and P-p70-S6K1). Total AMPK and p85-S6K1 and p70-S6K1 are shown. <em>&#x003b2;</em>-Actin was used as a loading control. Blots are representative of two biologic replicates. Experimental details are in <a href="#s2" rid="s2" class=" sec"><em>Materials and Methods</em></a>.</p></div></div></div><p>AICAR treatment of both BxPC-3 and HPAC cells induced AMPK hyperphosphorylation [3.87-fold (&#x000b1;0.17) and 1.32-fold (&#x000b1;0.03), respectively] compared with untreated controls. This was accompanied by decreased phospho-S6K1 (p85- and p70-S6K1) in both BxPC-3 [0.16 (&#x000b1;0.02) compared with the control value of 1] and HPAC [0.20 (&#x000b1;0.01)] cells. <strong>AGF347</strong> induced a modestly increased activation of AMPK in the BxPC-3 cells [1.93-fold (&#x000b1;0.09) increased P-AMPK] compared with HPAC cells [1.25-fold (&#x000b1;0.06)]. In BxPC-3 cells, <strong>AGF347</strong> treatment induced hypophosphorylation of S6K1 [0.62 (&#x000b1;0.04)] but not HPAC cells [1.01 (&#x000b1;0.02)] compared with controls.</p><p class="p p-last">These results suggest that AMPK activation and loss of mTOR signaling may contribute to the antitumor efficacy of <strong>AGF347</strong>. However, the magnitude of these effects varied in different tumor models.</p></div><div id="s21" class="sec"><p></p><h4 id="s21title" class="inline">Effects on Mitochondrial Respiration. </h4><p class="p p-first">As SHMT2 serves a critical role in respiratory chain protein synthesis via methylation of select mitochondrial transfer RNAs, with SHMT2 KO cells experiencing respiratory deficiencies (<a href="#B33" rid="B33" class=" bibr popnode">Lucas et al., 2018</a>; <a href="#B42" rid="B42" class=" bibr popnode">Minton et al., 2018</a>; <a href="#B44" rid="B44" class=" bibr popnode">Morscher et al., 2018</a>), we examined whether suppression of SHMT2 by <strong>AGF347</strong> resulted in an analogous effect on mitochondrial respiration. For these experiments, we used HCT116 WT and HCT116 SHMT2 KO cells (<a href="#B44" rid="B44" class=" bibr popnode">Morscher et al., 2018</a>) from our prior study (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>) to directly compare effects on the OCR resulting from inhibition of SHMT2 by <strong>AGF347</strong> to those resulting from complete KO of SHMT2. HCT116 cells were pretreated with vehicle (DMSO; WT and SHMT2 KO) or 10 <em>&#x000b5;</em>M <strong>AGF347</strong> (WT) for 48 hours as before (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). Cells were seeded, and the next day, they were subjected to a mitochondrial stress test (<a href="/pmc/articles/PMC6877291/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6</span></a>). As previously reported (<a href="#B33" rid="B33" class=" bibr popnode">Lucas et al., 2018</a>; <a href="#B42" rid="B42" class=" bibr popnode">Minton et al., 2018</a>; <a href="#B44" rid="B44" class=" bibr popnode">Morscher et al., 2018</a>), the SHMT2 KO cells showed a substantially reduced respiratory capacity relative to WT cells. In spite of the confirmed inhibition of SHMT2 (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>), <strong>AGF347</strong> caused no repressive effect on basal respiration, ATP production (H<sup>+</sup> leak), maximal respiration, or nonmitochondrial respiration compared with WT cells (<a href="/pmc/articles/PMC6877291/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC6877291/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247893265312"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f6.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f6.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247893265312"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Fig. 6.</a></div><!--caption a7--><div class="caption"><p>Effects of <strong>AGF347</strong> on mitochondrial respiration. OCR measurements of vehicle-treated HCT116 WT or SHMT2 KO cells and of <strong>AGF347</strong>-treated HCT116 WT cells during a mitochondrial stress test are shown. Experiments were performed with a Seahorse XFe24 analyzer with HCT116 cells pretreated with vehicle (DMSO; WT and SHMT2 KO) or 10 <em>&#x000b5;</em>M <strong>AGF347</strong> (WT) for 48 hours in glycine-replete medium with 60 <em>&#x000b5;</em>M adenosine. Oligomycin (1 <em>&#x000b5;</em>M), carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (1 <em>&#x000b5;</em>M), and rotenone/antimycin A (1 <em>&#x000b5;</em>M each) were sequentially added at the indicated time points to determine basal, maximal, and nonmitochondrial respiration, as well as H<sup>+</sup> leak. Results (mean values &#x000b1; S.E.) represent 12 technical replicates measured over two independent experiments. **<em>P</em> &#x0003c; 0.01. FCCP, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; Pairwise statistical comparisons were performed by two-sided unpaired <em>t</em> tests against WT. Experimental details are in <a href="#s2" rid="s2" class=" sec"><em>Materials and Methods</em></a>.</p></div></div></div></div><div id="s22" class="sec sec-last"><p></p><h4 id="s22title" class="inline">Impact of AGF347 on ROS and GSH Pools. </h4><p class="p p-first">SHMT2 is critical for synthesis of glycine for generation of GSH (<a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>), and previous work has shown de novo GSH biosynthesis is more sensitive to glycine depletion than either de novo purine or protein biosynthesis (<a href="#B12" rid="B12" class=" bibr popnode">Ducker et al., 2017</a>). GSH functions to scavenge ROS that are byproducts of oxidative phosphorylation, especially under hypoxic conditions that induce an &#x0201c;electron leak&#x0201d; from the electron transport chain (<a href="#B3" rid="B3" class=" bibr popnode">Chandel et al., 2000</a>; <a href="#B17" rid="B17" class=" bibr popnode">Guzy et al., 2005</a>).</p><p>To assess induction of ROS upon treatment with <strong>AGF347</strong> (10 <em>&#x003bc;</em>M), we treated HCT116, BxPC-3, HPAC, and MIA PaCa-2 cells with inhibitor for 24 hours under normoxic (21% O<sub>2</sub>, 5% CO<sub>2</sub>) and hypoxic [0.5% O<sub>2</sub>, 5% CO<sub>2</sub> (<a href="#B68" rid="B68" class=" bibr popnode">Ye et al., 2014</a>)] conditions. As controls, we included HCT116 SHMT1 KO and SHMT2 KO cells. To prevent rescue of GSH pools by extracellular glycine, we performed these experiments in <em>glycine-free</em> medium supplemented with adenosine (60 <em>&#x000b5;</em>M) (isolates effects of SHMT2 inhibition from those resulting from de novo purine biosynthesis inhibition). Total cellular ROS was measured with an H<sub>2</sub>DCFDA reporter assay (<a href="#B14" rid="B14" class=" bibr popnode">Eruslanov and Kusmartsev, 2010</a>). Functional induction of cellular hypoxia under 0.5% O<sub>2</sub> was reflected in elevated transcripts for carbonic anhydrase IX (<a href="/pmc/articles/PMC6877291/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7A</span></a>), an established hypoxia marker (<a href="#B1" rid="B1" class=" bibr popnode">Benej et al., 2014</a>). Under normoxic conditions (<a href="/pmc/articles/PMC6877291/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7B</span></a>), treatment with <strong>AGF347</strong> induced no significant accumulation of ROS in any of the cell lines. Conversely, under hypoxia (<a href="/pmc/articles/PMC6877291/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7C</span></a>), significant accumulation of ROS occurred in HCT116 WT (&#x0223c;2-fold) and HPAC cells (1.5-fold) treated with <strong>AGF347</strong>, although there was no increased ROS in BxPC-3 and MIA PaCA-2 cells treated with the inhibitor. HCT116 SHMT2 KO cells induced a 3-fold increase in ROS (under hypoxic conditions), whereas there was no significant increase in ROS in SHMT1 KO cells. Thus, complete loss of SHMT2 in HCT116 cells results in increased ROS. Further, the extent of ROS induction with <strong>AGF347</strong> varies with different cell lines. These results suggest that ROS could be an important mediator of <strong>AGF347</strong> antitumor effects in hypoxic tumors.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC6877291/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140247884961744"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6877291_mol.119.117937f7.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mol.119.117937f7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6877291/bin/mol.119.117937f7.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140247884961744"><a target="object" rel="noopener" href="/pmc/articles/PMC6877291/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC6877291/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Fig. 7.</a></div><!--caption a7--><div class="caption"><p>Effects of <strong>AGF347</strong> on ROS and GSH and total (GSH + GSSG) glutathione pools. (A) Carbonic anhydrase IX (CA9) transcripts were measured as a biologic readout for hypoxia in HCT116 (WT, SHMT1 KO, and SHMT2 KO) and PaC (BxPC-3, HPAC, and MIA PaCa-2) cells incubated for 24 hours under normoxic (21% O<sub>2</sub>, 5% CO<sub>2</sub>) or hypoxic (0.5% O<sub>2</sub>, 5% CO<sub>2</sub>) conditions. (B and C) Data are shown for cellular ROS generation in vehicle- or <strong>AGF347</strong>-treated cells under normoxia (B) or hypoxia (C). (D) Data are shown for GSH and total glutathione (GSH + GSSG) in vehicle- or <strong>AGF347</strong>-treated cells under hypoxic conditions. CA9 experiments reflect three biologic replicates, GSH/GSSG experiments reflect eight technical replicates over two independent experiments, and ROS experiments represent 16 technical replicates over two independent experiments. GSH/GSSG and ROS results (mean values &#x000b1; S.D.) were normalized to cellular proteins. <sup>#</sup><em>P</em> &#x0003c; 0.10; *<em>P</em> &#x0003c; 0.05; **<em>P</em> &#x0003c; 0.01; ***<em>P</em> &#x0003c; 0.001. ns, not significant. Pairwise statistical comparisons were performed by two-sided unpaired <em>t</em> tests against normoxia samples in (A) and respective WTs in (B)&#x02013;(D).</p></div></div></div><p>To assess the possibility that decreased GSH due to loss of glycine or redox potential resulting from loss of SHMT2 activity was causal in the increased ROS in certain cell lines, we assayed GSH in HCT116, BxPC-3, HPAC, and MIA PaCa-2 cells under hypoxic conditions. Consistent with the changes in ROS, both GSH and total glutathione (GSH + GSSG) pools were significantly decreased with <strong>AGF347</strong> treatment in HCT116 and HPAC cell lines, paralleling changes in ROS (<a href="/pmc/articles/PMC6877291/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7, C and D</span></a>). Although decreases in GSH and total glutathione were also detected in MIA PaCa-2 cells, these were unchanged in BxPC-3 cells. Interestingly, HCT116 SHMT2 KO cells showed substantially elevated ROS yet unchanged GSH and total glutathione.</p><p class="p p-last">Collectively, these results suggest that suppression of de novo GSH biosynthesis and elevated ROS are potential mechanisms of in vivo cytotoxic activity by <strong>AGF347</strong>, although this varies with different tumor cells.</p></div></div></div><div id="s23" class="tsec sec"><h2 class="head no_bottom_margin" id="s23title">Discussion</h2><p class="p p-first">Although targeting of C1 metabolism for cancer has shown clinical utility from the early days of chemotherapy to the present, the clinical effectiveness of drugs targeting these pathways is limited by their toxicities toward normal tissues. Therefore, agents targeting tumor-selective enzymes, such as those involved in mitochondrial C1 metabolism (<a href="#B47" rid="B47" class=" bibr popnode">Nilsson et al., 2014</a>), would offer immense clinical utility.</p><p>In this study, we characterized the cellular pharmacodynamics of <strong>AGF347</strong>, a prototype and lead analog of a novel series of 5-substituted pyrrolo[3,2-<em>d</em>]pyrimidine compounds that inhibit mitochondrial C1 metabolism at SHMT2, with downstream inhibitions of cytosolic C1 targets including SHMT1 and the de novo purine biosynthetic enzymes GARFTase and AICARFTase (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). We focused on a series of five PaC cell lines (including those with different KRAS mutation status) based on our previous results that established substantial antitumor efficacy of <strong>AGF347</strong> toward MIA PaCa-2, an aggressive PaC model with mutant KRAS (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). Whereas all of the analogs were active toward the PaC cell lines over an 11-fold range of growth inhibition, <strong>AGF347</strong> was consistently the most active of the series. Further, tumor selectivity was strongly implied as the pyrrolo[3,2-<em>d</em>]pyrimidine inhibitors were inert toward HPNE cells.</p><p>We characterized the transport properties for [<sup>3</sup>H]<strong>AGF347</strong>, including transport kinetics compared with [<sup>3</sup>H]MTX with both RFC and PCFT, the major transport systems for folates and related compounds in the PaC cell lines. Transport of <strong>AGF347</strong> by both RFC and PCFT was substantial. For the tumor-selective transporter PCFT, <strong>AGF347</strong> showed a binding affinity approaching those of the best PCFT substrates, <strong>AGF94</strong> and PMX (<a href="#B10" rid="B10" class=" bibr popnode">Desmoulin et al., 2012</a>), and far exceeding that of MTX. In the PaC cell lines, transport of [<sup>3</sup>H]<strong>AGF347</strong> by both PCFT and RFC was substantial at pH 6.8 (approximating pH conditions associated with the tumor microenvironment), although transport by RFC predominated.</p><p>As the pyrrolo[3,2-<em>d</em>]pyrimidine compounds target SHMT2 in the mitochondria (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>), we assessed the mitochondrial accumulation of [<sup>3</sup>H]<strong>AGF347</strong> in MIA PaCa-2 cells and in MFT-null glyB CHO cells transfected with human MFT. For both cell lines, significant [<sup>3</sup>H]<strong>AGF347</strong> accumulated in both the cytosol and mitochondria at levels similar to those for [<sup>3</sup>H]folic acid metabolites and far in excess of [<sup>3</sup>H]MTX. As MFT is the only known mitochondrial transporter (<a href="#B39" rid="B39" class=" bibr popnode">McCarthy et al., 2004</a>), the decreased mitochondrial accumulation of [<sup>3</sup>H]<strong>AGF347</strong> in MFT-null glyB cells compared with glyBTII cells transfected with human MFT (albeit less than for [<sup>3</sup>H]folic acid) suggested that mitochondrial uptake of <strong>AGF347</strong> must be at least partly mediated by MFT. However, partial (&#x0223c;80%) MFT knockdown in MIA PaCa-2 cells had a nominal impact on mitochondrial accumulation of [<sup>3</sup>H]<strong>AGF347</strong> in contrast to [<sup>3</sup>H]folic acid. This suggests that even a small amount of MFT is sufficient to mediate accumulation of <strong>AGF347</strong> in the mitochondria, and/or that an additional mitochondrial transporter must also be involved in <strong>AGF347</strong> uptake. Following uptake, <strong>AGF347</strong> polyglutamates accumulated in the mitochondria, which likely contribute to sustained SHMT2 inhibition and in vivo antitumor activity of <strong>AGF347</strong> (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). By analogy with pemetrexed, it is likely that the polyglutamyl derivatives that accumulate in the mitochondria and cytosol contribute to inhibition of cytosolic enzyme targets and are more potent enzyme inhibitors than the K<sub>i</sub> values for the monoglutamate form would suggest (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). By analogy with folate polyglutamates (<a href="#B26" rid="B26" class=" bibr popnode">Lawrence et al., 2014</a>), <strong>AGF347</strong> polyglutamates are unlikely to be MFT substrates, and the accumulation of <strong>AGF347</strong> polyglutamates in the cytosol may actually restrict drug accumulation in the mitochondria and SHMT2 inhibition.</p><p>We investigated mechanisms that directly or indirectly contribute to the antitumor effects of <strong>AGF347</strong> secondary to targeting SHMT2 in mitochondria and de novo purine biosynthesis and SHMT1 in the cytosol (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). These include possible effects on AMPK and mTOR signaling, mitochondrial respiration, and GSH and GSSG levels and ROS scavenging. For BxPC-3 cells with WT KRAS, <strong>AGF347</strong> increased AMPK phosphorylation and suppressed mTOR signaling, suggesting that loss of mTOR signaling plays a role in the antitumor efficacy of <strong>AGF347</strong> in these cells. Inhibitor effects on AMPK and S6K1 were muted in KRAS-mutant HPAC cells, suggesting Ras-ERK cross-talk with AMPK-mTOR signaling could interfere with this mechanism (<a href="#B41" rid="B41" class=" bibr popnode">Mendoza et al., 2011</a>). However, whether effects of AMPK phosphorylation and mTOR signaling might be related to KRAS status would require additional experiments in a wider range of KRAS WT and mutant cells to allow statistical analysis. There was no effect of <strong>AGF347</strong> on mitochondrial respiration, in contrast to that resulting from genetic KO of SHMT2 in HCT116 cells. This suggests that the extent of SHMT2 inhibition by <strong>AGF347</strong> is incomplete and likely insufficient to suppress mitochondrial respiration, consistent with the findings of <a href="#B42" rid="B42" class=" bibr popnode">Minton et al. (2018)</a>, who reported that impaired mitochondrial respiration requires complete suppression of SHMT2 activity. <strong>AGF347</strong> effected decreased levels of GSH and total glutathione, likely reflecting the principal role of SHMT2 in the synthesis of glycine required for GSH and its impact on redox balance (<a href="#B13" rid="B13" class=" bibr popnode">Ducker and Rabinowitz, 2017</a>). For HCT116 SHMT2 KO cells, GSH and total glutathione pools were unchanged, possibly due to a compensatory reversal of the SHMT1 reaction (<a href="#B11" rid="B11" class=" bibr popnode">Ducker et al., 2016</a>), which results in restored glycine synthesis and the preservation of the GSH pools. As this was not seen with cells treated with <strong>AGF347</strong>, this likely reflects the dual inhibition of both SHMT1 and SHMT2 by this compound (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). Decreased total glutathione pools were accompanied by increased ROS (under hypoxic conditions) in some, but not all, cell lines, possibly reflecting (in part) reliance on alternate antioxidant pathways, such as thioredoxin (<a href="#B2" rid="B2" class=" bibr popnode">Birben et al., 2012</a>).</p><p class="p p-last">In conclusion, the results described herein underscore the biologic novelty and multifaceted mechanisms of action for the 5-substituted pyrrolo[3,2-<em>d</em>]pyrimidine compounds typified by <strong>AGF347</strong> and are entirely consistent with its substantial in vivo antitumor potency and nominal and reversible toxicity (<a href="#B7" rid="B7" class=" bibr popnode">Dekhne et al., 2019</a>). Tumor specificity for this series of compounds is broad and likely reflects a selective reliance on mitochondrial C1 metabolism (<a href="#B20" rid="B20" class=" bibr popnode">Jain et al., 2012</a>; <a href="#B47" rid="B47" class=" bibr popnode">Nilsson et al., 2014</a>) and de novo purine biosynthesis over purine salvage (<a href="#B57" rid="B57" class=" bibr popnode">Subhi et al., 2004</a>) in cancer cells, with downstream inhibition of mTOR signaling, decreased GSH pools, and increased ROS. This series of compounds affords an exciting new platform for broad-spectrum anticancer drug development.</p></div><div id="ack-a.s.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.s.btitle">Acknowledgments</h2><div class="sec"><p>We thank Dr. Izabela Podgorski, Mackenzie Herroon, and Erandi Rajagurubandara (Wayne State University) for their assistance with the hypoxia experiments.</p></div></div><div id="glossary-a.s.c" class="tsec sec"><h2 class="head no_bottom_margin" id="glossary-a.s.ctitle">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td id="G1"><strong>AGF291</strong></td><td>(4-(3-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)propyl)benzoyl)-<span class="small-caps">l</span>-glutamic acid</td></tr><tr><td id="G2"><strong>AGF320</strong></td><td>(5-(5-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)pentyl)thiophene-2-carbonyl)-<span class="small-caps">l</span>-glutamic acid</td></tr><tr><td id="G3"><strong>AGF347</strong></td><td>(4-(4-(2-amino-4-oxo-3,4-dihydro-5<em>H</em>-pyrrolo[3,2-<em>d</em>]pyrimidin-5-yl)butyl)-2-fluorobenzoyl)-<span class="small-caps">l</span>-glutamic acid</td></tr><tr><td id="G4"><strong>AGF94</strong></td><td><em>N</em>-((5-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-<em>d</em>]pyrimidin-6-yl)propyl]thiophen-2-yl)carbonyl)-<span class="small-caps">l</span>-glutamic acid</td></tr><tr><td id="G5">AICA</td><td>5-aminoimidazole-4-carboxamide</td></tr><tr><td id="G6">AICAR</td><td>5-aminoimidazole-4-carboxamide ribonucleoside</td></tr><tr><td id="G7">AICARFTase</td><td>AICA ribonucleotide formyltransferase</td></tr><tr><td id="G8">AMPK</td><td>AMP-activated protein kinase</td></tr><tr><td id="G9">C1</td><td>one-carbon</td></tr><tr><td id="G10">FFRPMI</td><td>folate-free RPMI 1640</td></tr><tr><td id="G11">FPGS</td><td>folylpoly-<em>&#x003b3;</em>-glutamate synthetase</td></tr><tr><td id="G12">GARFTase</td><td>glycinamide ribonucleotide formyltransferase</td></tr><tr><td id="G13">GSH</td><td>reduced glutathione</td></tr><tr><td id="G14">GSSG</td><td>glutathione disulfide</td></tr><tr><td id="G15">H<sub>2</sub>DCFDA</td><td>2&#x02032;,7&#x02032;-dichlorodihydrofluorescein diacetate</td></tr><tr><td>HPLC</td><td>high performance liquid chromatography</td></tr><tr><td id="G16">HPNE</td><td>human pancreas normal epithelial</td></tr><tr><td id="G17">KD</td><td>knockdown</td></tr><tr><td id="G18">KO</td><td>knockout</td></tr><tr><td id="G19">LDH</td><td>lactate dehydrogenase</td></tr><tr><td id="G20"><em>&#x003b1;</em>MEM</td><td><em>&#x003b1;</em>-minimal essential medium</td></tr><tr><td id="G21">MES</td><td>2-(<em>N</em>-morpholino)ethanesulfonic acid</td></tr><tr><td id="G22">MFT</td><td>mitochondrial folate transporter</td></tr><tr><td id="G23">MS</td><td>mannitol-sucrose</td></tr><tr><td id="G24">MTHFD</td><td>5,10-methylene THF dehydrogenase</td></tr><tr><td id="G25">mTOR</td><td>mammalian target of rapamycin</td></tr><tr><td id="G26">MTX</td><td>methotrexate</td></tr><tr><td id="G27">NTC</td><td>nontargeted control</td></tr><tr><td id="G28">OCR</td><td>oxygen consumption rate</td></tr><tr><td id="G29">PaC</td><td>pancreatic cancer</td></tr><tr><td id="G30">P-AMPK</td><td>phospho-AMPK</td></tr><tr><td id="G31">PCFT</td><td>proton-coupled folate transporter</td></tr><tr><td id="G32">PMX</td><td>pemetrexed</td></tr><tr><td id="G33">PT523</td><td><em>N</em><sup><em>&#x003b1;</em></sup>-(4-amino-4-deoxypteroyl)-<em>N</em><sup><em>&#x003b4;</em></sup>-hemiphthaloyl-l-ornithine</td></tr><tr><td id="G34">R2</td><td>MTXRIIOua<sup>R</sup>2-4</td></tr><tr><td id="G35">RFC</td><td>reduced folate carrier</td></tr><tr><td id="G36">ROS</td><td>reactive oxygen species</td></tr><tr><td id="G37">RT-PCR</td><td>reverse-transcription polymerase chain reaction</td></tr><tr><td id="G38">SDH</td><td>succinate dehydrogenase</td></tr><tr><td id="G39">SHMT</td><td>serine hydroxymethyltransferase</td></tr><tr><td id="G40">THF</td><td>tetrahydrofolate</td></tr><tr><td id="G41">WT</td><td>wild-type</td></tr></tbody></table></div></div></div><div id="notes-a.s.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.s.dtitle">Authorship Contributions</h2><p><em>Participated in research design:</em> Dekhne, Ning, Kalpage, Hou, H&#x000fc;ttemann, Matherly.</p><p><em>Conducted experiments:</em> Dekhne, Ning, Kalpage, Fr&#x000fc;hauf, Wallace-Povirk, O&#x02019;Connor.</p><p><em>Contributed new reagents or analytic tools:</em> Nayeen, Shah, Gangjee.</p><p><em>Performed data analysis:</em> Dekhne, Ning, Fr&#x000fc;hauf, Kim, Matherly.</p><p><em>Wrote or contributed to the writing of the manuscript:</em> Dekhne, Hou, Gangjee, Matherly.</p></div><div id="fn-group-a.s.a" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.s.atitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN3"><p class="p p-first-last">This work was supported in part by the National Institutes of Health [R01 CA53535 (L.H.M. and Z.H.), R01 CA152316 (L.H.M. and A.G.), R01 CA166711 (A.G. and L.H.M.), T32 CA009531 (A.S.D. and A.W.-P.), F30 CA228221 (A.S.D.), F31 CA022453 (A.W.-P.), and P30 CA022453 (S.K.)], a pilot Small Molecule Drug Discovery Grant from the Karmanos Cancer Institute (Z.H. and L.H.M.), the Eunice and Milton Ring Endowed Chair for Cancer Research (L.H.M.), and the Duquesne University Adrian Van Kaam Chair in Scholarly Excellence (A.G.).</p></p><p class="fn sec" id="FN4"><p class="p p-first-last"><a href="https://doi.org/10.1124/mol.119.117937" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://doi.org/10.1124/mol.119.117937</a>.</p></p><p class="fn sec" id="FN5"><p class="p p-first-last"><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is sbox.jpg" src="/pmc/articles/PMC6877291/bin/sbox.jpg" />This article has supplemental material available at <a href="http://molpharm.aspetjournals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">molpharm.aspetjournals.org</a>.</p></p></div></div><div id="ref-list-a.s.e" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.s.etitle">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="first-line-outdent"><li id="B1"><span class="mixed-citation">Benej M, Pastorekova S, Pastorek J. (2014) <span class="ref-title">Carbonic anhydrase IX: regulation and role in cancer</span>. <span class="ref-journal">Subcell Biochem</span>
<span class="ref-vol">75</span>:199&#x02013;219. [<a href="https://pubmed.ncbi.nlm.nih.gov/24146381" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Subcell+Biochem&amp;title=Carbonic+anhydrase+IX:+regulation+and+role+in+cancer&amp;author=M+Benej&amp;author=S+Pastorekova&amp;author=J+Pastorek&amp;volume=75&amp;publication_year=2014&amp;pages=199-219&amp;pmid=24146381&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="mixed-citation">Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. (2012) <span class="ref-title">Oxidative stress and antioxidant defense</span>. <span class="ref-journal">World Allergy Organ J</span>
<span class="ref-vol">5</span>:9&#x02013;19. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3488923/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23268465" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+Allergy+Organ+J&amp;title=Oxidative+stress+and+antioxidant+defense&amp;author=E+Birben&amp;author=UM+Sahiner&amp;author=C+Sackesen&amp;author=S+Erzurum&amp;author=O+Kalayci&amp;volume=5&amp;publication_year=2012&amp;pages=9-19&amp;pmid=23268465&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="mixed-citation">Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. (2000) <span class="ref-title">Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">275</span>:25130&#x02013;25138. [<a href="https://pubmed.ncbi.nlm.nih.gov/10833514" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Reactive+oxygen+species+generated+at+mitochondrial+complex+III+stabilize+hypoxia-inducible+factor-1alpha+during+hypoxia:+a+mechanism+of+O2+sensing&amp;author=NS+Chandel&amp;author=DS+McClintock&amp;author=CE+Feliciano&amp;author=TM+Wood&amp;author=JA+Melendez&amp;volume=275&amp;publication_year=2000&amp;pages=25130-25138&amp;pmid=10833514&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="mixed-citation">Chattopadhyay S, Moran RG, Goldman ID. (2007) <span class="ref-title">Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications</span>. <span class="ref-journal">Mol Cancer Ther</span>
<span class="ref-vol">6</span>:404&#x02013;417. [<a href="https://pubmed.ncbi.nlm.nih.gov/17308042" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Pemetrexed:+biochemical+and+cellular+pharmacology,+mechanisms,+and+clinical+applications&amp;author=S+Chattopadhyay&amp;author=RG+Moran&amp;author=ID+Goldman&amp;volume=6&amp;publication_year=2007&amp;pages=404-417&amp;pmid=17308042&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B5"><span class="mixed-citation">Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, Berjian R, Douglass HO, Martin EW, Chu TM. (1982) <span class="ref-title">Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites</span>. <span class="ref-journal">In Vitro</span>
<span class="ref-vol">18</span>:24&#x02013;34. [<a href="https://pubmed.ncbi.nlm.nih.gov/7182348" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=In+Vitro&amp;title=Human+pancreatic+adenocarcinoma:+in+vitro+and+in+vivo+morphology+of+a+new+tumor+line+established+from+ascites&amp;author=WH+Chen&amp;author=JS+Horoszewicz&amp;author=SS+Leong&amp;author=T+Shimano&amp;author=R+Penetrante&amp;volume=18&amp;publication_year=1982&amp;pages=24-34&amp;pmid=7182348&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="mixed-citation">Clayton DA, Shadel GS. (2014) <span class="ref-title">Isolation of mitochondria from tissue culture cells</span>. <span class="ref-journal">Cold Spring Harbor Protocols</span>
<span class="ref-vol">2014</span> (<span class="ref-iss">10</span>):pdb.prot080002. [<a href="https://pubmed.ncbi.nlm.nih.gov/25275104" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cold+Spring+Harbor+Protocols&amp;title=Isolation+of+mitochondria+from+tissue+culture+cells&amp;author=DA+Clayton&amp;author=GS+Shadel&amp;volume=2014&amp;issue=10&amp;publication_year=2014&amp;pages=pdb.prot080002&amp;pmid=25275104&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="mixed-citation">Dekhne AS, Shah K, Ducker GS, Katinas JM, Wong-Roushar J, Nayeen MJ, Doshi A, Ning C, Bao X, Fr&#x000fc;hauf J, et al. (2019) <span class="ref-title">Novel pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy</span>. <span class="ref-journal">Mol Cancer Ther</span>
<span class="ref-vol">18</span>:1787&#x02013;1799. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6774887/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31289137" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Novel+pyrrolo[3,2-d]pyrimidine+compounds+target+mitochondrial+and+cytosolic+one-carbon+metabolism+with+broad-spectrum+antitumor+efficacy&amp;author=AS+Dekhne&amp;author=K+Shah&amp;author=GS+Ducker&amp;author=JM+Katinas&amp;author=J+Wong-Roushar&amp;volume=18&amp;publication_year=2019&amp;pages=1787-1799&amp;pmid=31289137&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="mixed-citation">Deng Y, Wang Y, Cherian C, Hou Z, Buck SA, Matherly LH, Gangjee A. (2008) <span class="ref-title">Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activity</span>. <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">51</span>:5052&#x02013;5063. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2748117/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18680275" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Synthesis+and+discovery+of+high+affinity+folate+receptor-specific+glycinamide+ribonucleotide+formyltransferase+inhibitors+with+antitumor+activity&amp;author=Y+Deng&amp;author=Y+Wang&amp;author=C+Cherian&amp;author=Z+Hou&amp;author=SA+Buck&amp;volume=51&amp;publication_year=2008&amp;pages=5052-5063&amp;pmid=18680275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="mixed-citation">Deng Y, Zhou X, Kugel Desmoulin S, Wu J, Cherian C, Hou Z, Matherly LH, Gangjee A. (2009) <span class="ref-title">Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry</span>. <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">52</span>:2940&#x02013;2951. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2730022/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19371039" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Synthesis+and+biological+activity+of+a+novel+series+of+6-substituted+thieno[2,3-d]pyrimidine+antifolate+inhibitors+of+purine+biosynthesis+with+selectivity+for+high+affinity+folate+receptors+over+the+reduced+folate+carrier+and+proton-coupled+folate+transporter+for+cellular+entry&amp;author=Y+Deng&amp;author=X+Zhou&amp;author=S+Kugel+Desmoulin&amp;author=J+Wu&amp;author=C+Cherian&amp;volume=52&amp;publication_year=2009&amp;pages=2940-2951&amp;pmid=19371039&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="mixed-citation">Desmoulin SK, Hou Z, Gangjee A, Matherly LH. (2012) <span class="ref-title">The human proton-coupled folate transporter: biology and therapeutic applications to cancer</span>. <span class="ref-journal">Cancer Biol Ther</span>
<span class="ref-vol">13</span>:1355&#x02013;1373. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3542225/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22954694" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=The+human+proton-coupled+folate+transporter:+biology+and+therapeutic+applications+to+cancer&amp;author=SK+Desmoulin&amp;author=Z+Hou&amp;author=A+Gangjee&amp;author=LH+Matherly&amp;volume=13&amp;publication_year=2012&amp;pages=1355-1373&amp;pmid=22954694&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B11"><span class="mixed-citation">Ducker GS, Chen L, Morscher RJ, Ghergurovich JM, Esposito M, Teng X, Kang Y, Rabinowitz JD. (2016) <span class="ref-title">Reversal of cytosolic one-carbon flux compensates for loss of the mitochondrial folate pathway</span>. <span class="ref-journal">Cell Metab</span>
<span class="ref-vol">24</span>:640&#x02013;641. [<a href="https://pubmed.ncbi.nlm.nih.gov/27732838" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Reversal+of+cytosolic+one-carbon+flux+compensates+for+loss+of+the+mitochondrial+folate+pathway&amp;author=GS+Ducker&amp;author=L+Chen&amp;author=RJ+Morscher&amp;author=JM+Ghergurovich&amp;author=M+Esposito&amp;volume=24&amp;publication_year=2016&amp;pages=640-641&amp;pmid=27732838&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="mixed-citation">Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, Friedman A, Manfredi MG, Gitai Z, Kim H, et al. (2017) <span class="ref-title">Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma</span>. <span class="ref-journal">Proc Natl Acad Sci USA</span>
<span class="ref-vol">114</span>:11404&#x02013;11409. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5664509/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29073064" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Human+SHMT+inhibitors+reveal+defective+glycine+import+as+a+targetable+metabolic+vulnerability+of+diffuse+large+B-cell+lymphoma&amp;author=GS+Ducker&amp;author=JM+Ghergurovich&amp;author=N+Mainolfi&amp;author=V+Suri&amp;author=SK+Jeong&amp;volume=114&amp;publication_year=2017&amp;pages=11404-11409&amp;pmid=29073064&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="mixed-citation">Ducker GS, Rabinowitz JD. (2017) <span class="ref-title">One-carbon metabolism in health and disease</span>. <span class="ref-journal">Cell Metab</span>
<span class="ref-vol">25</span>:27&#x02013;42. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5353360/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27641100" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=One-carbon+metabolism+in+health+and+disease&amp;author=GS+Ducker&amp;author=JD+Rabinowitz&amp;volume=25&amp;publication_year=2017&amp;pages=27-42&amp;pmid=27641100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="mixed-citation">Eruslanov E, Kusmartsev S. (2010) Identification of ROS using oxidized DCFDA and flow-cytometry, in <span class="ref-journal">Advanced Protocols in Oxidative Stress II</span> (Armstrong D. ed) pp 57&#x02013;72, Humana Press, Totowa, NJ. [<a href="https://pubmed.ncbi.nlm.nih.gov/20072909" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Advanced+Protocols+in+Oxidative+Stress+II&amp;author=E+Eruslanov&amp;author=S+Kusmartsev&amp;publication_year=2010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="mixed-citation">Flintoff WF, Davidson SV, Siminovitch L. (1976) <span class="ref-title">Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells</span>. <span class="ref-journal">Somatic Cell Genet</span>
<span class="ref-vol">2</span>:245&#x02013;261. [<a href="https://pubmed.ncbi.nlm.nih.gov/1028172" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Somatic+Cell+Genet&amp;title=Isolation+and+partial+characterization+of+three+methotrexate-resistant+phenotypes+from+Chinese+hamster+ovary+cells&amp;author=WF+Flintoff&amp;author=SV+Davidson&amp;author=L+Siminovitch&amp;volume=2&amp;publication_year=1976&amp;pages=245-261&amp;pmid=1028172&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="mixed-citation">Gower WR, Jr, Risch RM, Godellas CV, Fabri PJ. (1994) <span class="ref-title">HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line</span>. <span class="ref-journal">In Vitro Cell Dev Biol Anim</span>
<span class="ref-vol">30A</span>:151&#x02013;161. [<a href="https://pubmed.ncbi.nlm.nih.gov/25939163" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=In+Vitro+Cell+Dev+Biol+Anim&amp;title=HPAC,+a+new+human+glucocorticoid-sensitive+pancreatic+ductal+adenocarcinoma+cell+line&amp;author=WR+Gower&amp;author=RM+Risch&amp;author=CV+Godellas&amp;author=PJ+Fabri&amp;volume=30A&amp;publication_year=1994&amp;pages=151-161&amp;pmid=25939163&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="mixed-citation">Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT. (2005) <span class="ref-title">Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing</span>. <span class="ref-journal">Cell Metab</span>
<span class="ref-vol">1</span>:401&#x02013;408. [<a href="https://pubmed.ncbi.nlm.nih.gov/16054089" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Mitochondrial+complex+III+is+required+for+hypoxia-induced+ROS+production+and+cellular+oxygen+sensing&amp;author=RD+Guzy&amp;author=B+Hoyos&amp;author=E+Robin&amp;author=H+Chen&amp;author=L+Liu&amp;volume=1&amp;publication_year=2005&amp;pages=401-408&amp;pmid=16054089&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="mixed-citation">Hanahan D, Weinberg RA. (2011) <span class="ref-title">Hallmarks of cancer: the next generation</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">144</span>:646&#x02013;674. [<a href="https://pubmed.ncbi.nlm.nih.gov/21376230" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Hallmarks+of+cancer:+the+next+generation&amp;author=D+Hanahan&amp;author=RA+Weinberg&amp;volume=144&amp;publication_year=2011&amp;pages=646-674&amp;pmid=21376230&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="mixed-citation">Hoxhaj G, Hughes-Hallett J, Timson RC, Ilagan E, Yuan M, Asara JM, Ben-Sahra I, Manning BD. (2017) <span class="ref-title">The mTORC1 signaling network senses changes in cellular purine nucleotide levels</span>. <span class="ref-journal">Cell Rep</span>
<span class="ref-vol">21</span>:1331&#x02013;1346. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5689476/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29091770" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep&amp;title=The+mTORC1+signaling+network+senses+changes+in+cellular+purine+nucleotide+levels&amp;author=G+Hoxhaj&amp;author=J+Hughes-Hallett&amp;author=RC+Timson&amp;author=E+Ilagan&amp;author=M+Yuan&amp;volume=21&amp;publication_year=2017&amp;pages=1331-1346&amp;pmid=29091770&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="mixed-citation">Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, Kafri R, Kirschner MW, Clish CB, Mootha VK. (2012) <span class="ref-title">Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation</span>. <span class="ref-journal">Science</span>
<span class="ref-vol">336</span>:1040&#x02013;1044. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3526189/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22628656" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Metabolite+profiling+identifies+a+key+role+for+glycine+in+rapid+cancer+cell+proliferation&amp;author=M+Jain&amp;author=R+Nilsson&amp;author=S+Sharma&amp;author=N+Madhusudhan&amp;author=T+Kitami&amp;volume=336&amp;publication_year=2012&amp;pages=1040-1044&amp;pmid=22628656&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="mixed-citation">Kim D, Fiske BP, Birsoy K, Freinkman E, Kami K, Possemato R, Chudnovsky Y, Pacold ME, Chen WW, Cantor JR, et al. (2015) <span class="ref-title">SHMT2 drives glioma cell survival in the tumor microenvironment but imposes a dependence on glycine clearance</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">520</span>:363&#x02013;367. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4533874/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25855294" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=SHMT2+drives+glioma+cell+survival+in+the+tumor+microenvironment+but+imposes+a+dependence+on+glycine+clearance&amp;author=D+Kim&amp;author=BP+Fiske&amp;author=K+Birsoy&amp;author=E+Freinkman&amp;author=K+Kami&amp;volume=520&amp;publication_year=2015&amp;pages=363-367&amp;pmid=25855294&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B22"><span class="mixed-citation">Kolaj-Robin O, O&#x02019;Kane SR, Nitschke W, L&#x000e9;ger C, Baymann F, Soulimane T. (2011) <span class="ref-title">Biochemical and biophysical characterization of succinate: quinone reductase from Thermus thermophilus</span>. <span class="ref-journal">Biochim Biophys Acta</span>
<span class="ref-vol">1807</span>:68&#x02013;79. [<a href="https://pubmed.ncbi.nlm.nih.gov/20951673" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=Biochemical+and+biophysical+characterization+of+succinate:+quinone+reductase+from+Thermus+thermophilus&amp;author=O+Kolaj-Robin&amp;author=SR+O&#x02019;Kane&amp;author=W+Nitschke&amp;author=C+L&#x000e9;ger&amp;author=F+Baymann&amp;volume=1807&amp;publication_year=2011&amp;pages=68-79&amp;pmid=20951673&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B23"><span class="mixed-citation">Kugel Desmoulin S, Wang L, Hales E, Polin L, White K, Kushner J, Stout M, Hou Z, Cherian C, Gangjee A, et al. (2011) <span class="ref-title">Therapeutic targeting of a novel 6-substituted pyrrolo [2,3-d]pyrimidine thienoyl antifolate to human solid tumors based on selective uptake by the proton-coupled folate transporter</span>. <span class="ref-journal">Mol Pharmacol</span>
<span class="ref-vol">80</span>:1096&#x02013;1107. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3228537/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21940787" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;title=Therapeutic+targeting+of+a+novel+6-substituted+pyrrolo+[2,3-d]pyrimidine+thienoyl+antifolate+to+human+solid+tumors+based+on+selective+uptake+by+the+proton-coupled+folate+transporter&amp;author=S+Kugel+Desmoulin&amp;author=L+Wang&amp;author=E+Hales&amp;author=L+Polin&amp;author=K+White&amp;volume=80&amp;publication_year=2011&amp;pages=1096-1107&amp;pmid=21940787&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B24"><span class="mixed-citation">Laemmli UK. (1970) <span class="ref-title">Cleavage of structural proteins during the assembly of the head of bacteriophage T4</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">227</span>:680&#x02013;685. [<a href="https://pubmed.ncbi.nlm.nih.gov/5432063" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cleavage+of+structural+proteins+during+the+assembly+of+the+head+of+bacteriophage+T4&amp;author=UK+Laemmli&amp;volume=227&amp;publication_year=1970&amp;pages=680-685&amp;pmid=5432063&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B25"><span class="mixed-citation">Lawrence SA, Hackett JC, Moran RG. (2011) <span class="ref-title">Tetrahydrofolate recognition by the mitochondrial folate transporter</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">286</span>:31480&#x02013;31489. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3173085/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21768094" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Tetrahydrofolate+recognition+by+the+mitochondrial+folate+transporter&amp;author=SA+Lawrence&amp;author=JC+Hackett&amp;author=RG+Moran&amp;volume=286&amp;publication_year=2011&amp;pages=31480-31489&amp;pmid=21768094&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B26"><span class="mixed-citation">Lawrence SA, Titus SA, Ferguson J, Heineman AL, Taylor SM, Moran RG. (2014) <span class="ref-title">Mammalian mitochondrial and cytosolic folylpolyglutamate synthetase maintain the subcellular compartmentalization of folates</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">289</span>:29386&#x02013;29396. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4200287/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25164808" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Mammalian+mitochondrial+and+cytosolic+folylpolyglutamate+synthetase+maintain+the+subcellular+compartmentalization+of+folates&amp;author=SA+Lawrence&amp;author=SA+Titus&amp;author=J+Ferguson&amp;author=AL+Heineman&amp;author=SM+Taylor&amp;volume=289&amp;publication_year=2014&amp;pages=29386-29396&amp;pmid=25164808&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B27"><span class="mixed-citation">Lee KM, Nguyen C, Ulrich AB, Pour PM, Ouellette MM. (2003) <span class="ref-title">Immortalization with telomerase of the Nestin-positive cells of the human pancreas</span>. <span class="ref-journal">Biochem Biophys Res Commun</span>
<span class="ref-vol">301</span>:1038&#x02013;1044. [<a href="https://pubmed.ncbi.nlm.nih.gov/12589817" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Immortalization+with+telomerase+of+the+Nestin-positive+cells+of+the+human+pancreas&amp;author=KM+Lee&amp;author=C+Nguyen&amp;author=AB+Ulrich&amp;author=PM+Pour&amp;author=MM+Ouellette&amp;volume=301&amp;publication_year=2003&amp;pages=1038-1044&amp;pmid=12589817&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B28"><span class="mixed-citation">Liang S-Q, B&#x000fc;hrer ED, Berezowska S, Marti TM, Xu D, Froment L, Yang H, Hall SRR, Vassella E, Yang Z, et al. (2019) <span class="ref-title">mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer</span>. <span class="ref-journal">Oncogene</span>
<span class="ref-vol">38</span>:622&#x02013;636. [<a href="https://pubmed.ncbi.nlm.nih.gov/30171261" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=mTOR+mediates+a+mechanism+of+resistance+to+chemotherapy+and+defines+a+rational+combination+strategy+to+treat+KRAS-mutant+lung+cancer&amp;author=S-Q+Liang&amp;author=ED+B&#x000fc;hrer&amp;author=S+Berezowska&amp;author=TM+Marti&amp;author=D+Xu&amp;volume=38&amp;publication_year=2019&amp;pages=622-636&amp;pmid=30171261&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B29"><span class="mixed-citation">Lim HJ, Crowe P, Yang JL. (2015) <span class="ref-title">Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer</span>. <span class="ref-journal">J Cancer Res Clin Oncol</span>
<span class="ref-vol">141</span>:671&#x02013;689. [<a href="https://pubmed.ncbi.nlm.nih.gov/25146530" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cancer+Res+Clin+Oncol&amp;title=Current+clinical+regulation+of+PI3K/PTEN/Akt/mTOR+signalling+in+treatment+of+human+cancer&amp;author=HJ+Lim&amp;author=P+Crowe&amp;author=JL+Yang&amp;volume=141&amp;publication_year=2015&amp;pages=671-689&amp;pmid=25146530&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B30"><span class="mixed-citation">Lin BF, Huang RF, Shane B. (1993) <span class="ref-title">Regulation of folate and one-carbon metabolism in mammalian cells. III. Role of mitochondrial folylpoly-gamma-glutamate synthetase</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">268</span>:21674&#x02013;21679. [<a href="https://pubmed.ncbi.nlm.nih.gov/8408020" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Regulation+of+folate+and+one-carbon+metabolism+in+mammalian+cells.+III.+Role+of+mitochondrial+folylpoly-gamma-glutamate+synthetase&amp;author=BF+Lin&amp;author=RF+Huang&amp;author=B+Shane&amp;volume=268&amp;publication_year=1993&amp;pages=21674-21679&amp;pmid=8408020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B31"><span class="mixed-citation">Loayza-Puch F, Rooijers K, Buil LC, Zijlstra J, Oude Vrielink JF, Lopes R, Ugalde AP, van Breugel P, Hofland I, Wesseling J, et al. (2016) <span class="ref-title">Tumour-specific proline vulnerability uncovered by differential ribosome codon reading</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">530</span>:490&#x02013;494. [<a href="https://pubmed.ncbi.nlm.nih.gov/26878238" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Tumour-specific+proline+vulnerability+uncovered+by+differential+ribosome+codon+reading&amp;author=F+Loayza-Puch&amp;author=K+Rooijers&amp;author=LC+Buil&amp;author=J+Zijlstra&amp;author=JF+Oude+Vrielink&amp;volume=530&amp;publication_year=2016&amp;pages=490-494&amp;pmid=26878238&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B32"><span class="mixed-citation">Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951) <span class="ref-title">Protein measurement with the Folin phenol reagent</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">193</span>:265&#x02013;275. [<a href="https://pubmed.ncbi.nlm.nih.gov/14907713" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Protein+measurement+with+the+Folin+phenol+reagent&amp;author=OH+Lowry&amp;author=NJ+Rosebrough&amp;author=AL+Farr&amp;author=RJ+Randall&amp;volume=193&amp;publication_year=1951&amp;pages=265-275&amp;pmid=14907713&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B33"><span class="mixed-citation">Lucas S, Chen G, Aras S, Wang J. (2018) <span class="ref-title">Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells</span>. <span class="ref-journal">Life Sci Alliance</span>
<span class="ref-vol">1</span>:e201800036. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6238390/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30456347" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci+Alliance&amp;title=Serine+catabolism+is+essential+to+maintain+mitochondrial+respiration+in+mammalian+cells&amp;author=S+Lucas&amp;author=G+Chen&amp;author=S+Aras&amp;author=J+Wang&amp;volume=1&amp;publication_year=2018&amp;pages=e201800036&amp;pmid=30456347&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B34"><span class="mixed-citation">Magnuson B, Ekim B, Fingar DC. (2012) <span class="ref-title">Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks</span>. <span class="ref-journal">Biochem J</span>
<span class="ref-vol">441</span>:1&#x02013;21. [<a href="https://pubmed.ncbi.nlm.nih.gov/22168436" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;title=Regulation+and+function+of+ribosomal+protein+S6+kinase+(S6K)+within+mTOR+signalling+networks&amp;author=B+Magnuson&amp;author=B+Ekim&amp;author=DC+Fingar&amp;volume=441&amp;publication_year=2012&amp;pages=1-21&amp;pmid=22168436&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B35"><span class="mixed-citation">Mann KM, Ying H, Juan J, Jenkins NA, Copeland NG. (2016) <span class="ref-title">KRAS-related proteins in pancreatic cancer</span>. <span class="ref-journal">Pharmacol Ther</span>
<span class="ref-vol">168</span>:29&#x02013;42. [<a href="https://pubmed.ncbi.nlm.nih.gov/27595930" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;title=KRAS-related+proteins+in+pancreatic+cancer&amp;author=KM+Mann&amp;author=H+Ying&amp;author=J+Juan&amp;author=NA+Jenkins&amp;author=NG+Copeland&amp;volume=168&amp;publication_year=2016&amp;pages=29-42&amp;pmid=27595930&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B36"><span class="mixed-citation">Matherly LH, Hou Z, Deng Y. (2007) <span class="ref-title">Human reduced folate carrier: translation of basic biology to cancer etiology and therapy</span>. <span class="ref-journal">Cancer Metastasis Rev</span>
<span class="ref-vol">26</span>:111&#x02013;128. [<a href="https://pubmed.ncbi.nlm.nih.gov/17334909" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Metastasis+Rev&amp;title=Human+reduced+folate+carrier:+translation+of+basic+biology+to+cancer+etiology+and+therapy&amp;author=LH+Matherly&amp;author=Z+Hou&amp;author=Y+Deng&amp;volume=26&amp;publication_year=2007&amp;pages=111-128&amp;pmid=17334909&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B37"><span class="mixed-citation">Matherly LH, Voss MK, Anderson LA, Fry DW, Goldman ID. (1985) <span class="ref-title">Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">45</span>:1073&#x02013;1078. [<a href="https://pubmed.ncbi.nlm.nih.gov/2578870" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Enhanced+polyglutamylation+of+aminopterin+relative+to+methotrexate+in+the+Ehrlich+ascites+tumor+cell+in+vitro&amp;author=LH+Matherly&amp;author=MK+Voss&amp;author=LA+Anderson&amp;author=DW+Fry&amp;author=ID+Goldman&amp;volume=45&amp;publication_year=1985&amp;pages=1073-1078&amp;pmid=2578870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B38"><span class="mixed-citation">Matsudaira P. (1987) <span class="ref-title">Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">262</span>:10035&#x02013;10038. [<a href="https://pubmed.ncbi.nlm.nih.gov/3611052" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Sequence+from+picomole+quantities+of+proteins+electroblotted+onto+polyvinylidene+difluoride+membranes&amp;author=P+Matsudaira&amp;volume=262&amp;publication_year=1987&amp;pages=10035-10038&amp;pmid=3611052&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B39"><span class="mixed-citation">McCarthy EA, Titus SA, Taylor SM, Jackson-Cook C, Moran RG. (2004) <span class="ref-title">A mutation inactivating the mitochondrial inner membrane folate transporter creates a glycine requirement for survival of Chinese hamster cells</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">279</span>:33829&#x02013;33836. [<a href="https://pubmed.ncbi.nlm.nih.gov/15140890" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+mutation+inactivating+the+mitochondrial+inner+membrane+folate+transporter+creates+a+glycine+requirement+for+survival+of+Chinese+hamster+cells&amp;author=EA+McCarthy&amp;author=SA+Titus&amp;author=SM+Taylor&amp;author=C+Jackson-Cook&amp;author=RG+Moran&amp;volume=279&amp;publication_year=2004&amp;pages=33829-33836&amp;pmid=15140890&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B40"><span class="mixed-citation">Meiser J, Tumanov S, Maddocks O, Labuschagne CF, Athineos D, Van Den Broek N, Mackay GM, Gottlieb E, Blyth K, Vousden K, et al. (2016) <span class="ref-title">Serine one-carbon catabolism with formate overflow</span>. <span class="ref-journal">Sci Adv</span>
<span class="ref-vol">2</span>:e1601273. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5091358/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27819051" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Adv&amp;title=Serine+one-carbon+catabolism+with+formate+overflow&amp;author=J+Meiser&amp;author=S+Tumanov&amp;author=O+Maddocks&amp;author=CF+Labuschagne&amp;author=D+Athineos&amp;volume=2&amp;publication_year=2016&amp;pages=e1601273&amp;pmid=27819051&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B41"><span class="mixed-citation">Mendoza MC, Er EE, Blenis J. (2011) <span class="ref-title">The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation</span>. <span class="ref-journal">Trends Biochem Sci</span>
<span class="ref-vol">36</span>:320&#x02013;328. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3112285/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21531565" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biochem+Sci&amp;title=The+Ras-ERK+and+PI3K-mTOR+pathways:+cross-talk+and+compensation&amp;author=MC+Mendoza&amp;author=EE+Er&amp;author=J+Blenis&amp;volume=36&amp;publication_year=2011&amp;pages=320-328&amp;pmid=21531565&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B42"><span class="mixed-citation">Minton DR, Nam M, McLaughlin DJ, Shin J, Bayraktar EC, Alvarez SW, Sviderskiy VO, Papagiannakopoulos T, Sabatini DM, Birsoy K, et al. (2018) <span class="ref-title">Serine catabolism by SHMT2 is required for proper mitochondrial translation initiation and maintenance of formylmethionyl-tRNAs</span>. <span class="ref-journal">Mol Cell</span>
<span class="ref-vol">69</span>:610&#x02013;621.e5. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5819360/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29452640" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=Serine+catabolism+by+SHMT2+is+required+for+proper+mitochondrial+translation+initiation+and+maintenance+of+formylmethionyl-tRNAs&amp;author=DR+Minton&amp;author=M+Nam&amp;author=DJ+McLaughlin&amp;author=J+Shin&amp;author=EC+Bayraktar&amp;volume=69&amp;publication_year=2018&amp;pages=610-621.e5&amp;pmid=29452640&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B43"><span class="mixed-citation">Mitchell-Ryan S, Wang Y, Raghavan S, Ravindra MP, Hales E, Orr S, Cherian C, Hou Z, Matherly LH, Gangjee A. (2013) <span class="ref-title">Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity</span>. <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">56</span>:10016&#x02013;10032. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3917155/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24256410" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Discovery+of+5-substituted+pyrrolo[2,3-d]pyrimidine+antifolates+as+dual-acting+inhibitors+of+glycinamide+ribonucleotide+formyltransferase+and+5-aminoimidazole-4-carboxamide+ribonucleotide+formyltransferase+in+de+novo+purine+nucleotide+biosynthesis:+implications+of+inhibiting+5-aminoimidazole-4-carboxamide+ribonucleotide+formyltransferase+to+ampk+activation+and+antitumor+activity&amp;author=S+Mitchell-Ryan&amp;author=Y+Wang&amp;author=S+Raghavan&amp;author=MP+Ravindra&amp;author=E+Hales&amp;volume=56&amp;publication_year=2013&amp;pages=10016-10032&amp;pmid=24256410&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B44"><span class="mixed-citation">Morscher RJ, Ducker GS, Li SH, Mayer JA, Gitai Z, Sperl W, Rabinowitz JD. (2018) <span class="ref-title">Mitochondrial translation requires folate-dependent tRNA methylation</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">554</span>:128&#x02013;132. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6020024/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29364879" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Mitochondrial+translation+requires+folate-dependent+tRNA+methylation&amp;author=RJ+Morscher&amp;author=GS+Ducker&amp;author=SH+Li&amp;author=JA+Mayer&amp;author=Z+Gitai&amp;volume=554&amp;publication_year=2018&amp;pages=128-132&amp;pmid=29364879&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B45"><span class="mixed-citation">Munujos P, Coll-Cant&#x000ed; J, Gonz&#x000e1;lez-Sastre F, Gella FJ. (1993) <span class="ref-title">Assay of succinate dehydrogenase activity by a colorimetric-continuous method using iodonitrotetrazolium chloride as electron acceptor</span>. <span class="ref-journal">Anal Biochem</span>
<span class="ref-vol">212</span>:506&#x02013;509. [<a href="https://pubmed.ncbi.nlm.nih.gov/8214593" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Biochem&amp;title=Assay+of+succinate+dehydrogenase+activity+by+a+colorimetric-continuous+method+using+iodonitrotetrazolium+chloride+as+electron+acceptor&amp;author=P+Munujos&amp;author=J+Coll-Cant&#x000ed;&amp;author=F+Gonz&#x000e1;lez-Sastre&amp;author=FJ+Gella&amp;volume=212&amp;publication_year=1993&amp;pages=506-509&amp;pmid=8214593&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B46"><span class="mixed-citation">Newman AC, Maddocks ODK. (2017) <span class="ref-title">Serine and functional metabolites in cancer</span>. <span class="ref-journal">Trends Cell Biol</span>
<span class="ref-vol">27</span>:645&#x02013;657. [<a href="https://pubmed.ncbi.nlm.nih.gov/28601431" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Cell+Biol&amp;title=Serine+and+functional+metabolites+in+cancer&amp;author=AC+Newman&amp;author=ODK+Maddocks&amp;volume=27&amp;publication_year=2017&amp;pages=645-657&amp;pmid=28601431&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B47"><span class="mixed-citation">Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, Huang J, Asplund A, Mootha VK. (2014) <span class="ref-title">Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer</span>. <span class="ref-journal">Nat Commun</span>
<span class="ref-vol">5</span>:3128. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4106362/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24451681" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Metabolic+enzyme+expression+highlights+a+key+role+for+MTHFD2+and+the+mitochondrial+folate+pathway+in+cancer&amp;author=R+Nilsson&amp;author=M+Jain&amp;author=N+Madhusudhan&amp;author=NG+Sheppard&amp;author=L+Strittmatter&amp;volume=5&amp;publication_year=2014&amp;pages=3128&amp;pmid=24451681&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B48"><span class="mixed-citation">Noguchi K, Konno M, Koseki J, Nishida N, Kawamoto K, Yamada D, Asaoka T, Noda T, Wada H, Gotoh K, et al. (2018) <span class="ref-title">The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer</span>. <span class="ref-journal">Oncol Lett</span>
<span class="ref-vol">16</span>:1827&#x02013;1834. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6036444/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30008872" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Lett&amp;title=The+mitochondrial+one-carbon+metabolic+pathway+is+associated+with+patient+survival+in+pancreatic+cancer&amp;author=K+Noguchi&amp;author=M+Konno&amp;author=J+Koseki&amp;author=N+Nishida&amp;author=K+Kawamoto&amp;volume=16&amp;publication_year=2018&amp;pages=1827-1834&amp;pmid=30008872&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B49"><span class="mixed-citation">Racanelli AC, Rothbart SB, Heyer CL, Moran RG. (2009) <span class="ref-title">Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">69</span>:5467&#x02013;5474. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2706929/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19549896" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Therapeutics+by+cytotoxic+metabolite+accumulation:+pemetrexed+causes+ZMP+accumulation,+AMPK+activation,+and+mammalian+target+of+rapamycin+inhibition&amp;author=AC+Racanelli&amp;author=SB+Rothbart&amp;author=CL+Heyer&amp;author=RG+Moran&amp;volume=69&amp;publication_year=2009&amp;pages=5467-5474&amp;pmid=19549896&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B50"><span class="mixed-citation">Ravindra M, Wilson MR, Tong N, O&#x02019;Connor C, Karim M, Polin L, Wallace-Povirk A, White K, Kushner J, Hou Z, et al. (2018) <span class="ref-title">Fluorine-substituted pyrrolo[2,3- d]pyrimidine analogues with tumor targeting via cellular uptake by folate receptor &#x003b1; and the proton-coupled folate transporter and inhibition of de novo purine nucleotide biosynthesis</span>. <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">61</span>:4228&#x02013;4248. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6097718/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29701475" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Fluorine-substituted+pyrrolo[2,3-+d]pyrimidine+analogues+with+tumor+targeting+via+cellular+uptake+by+folate+receptor+&#x003b1;+and+the+proton-coupled+folate+transporter+and+inhibition+of+de+novo+purine+nucleotide+biosynthesis&amp;author=M+Ravindra&amp;author=MR+Wilson&amp;author=N+Tong&amp;author=C+O&#x02019;Connor&amp;author=M+Karim&amp;volume=61&amp;publication_year=2018&amp;pages=4228-4248&amp;pmid=29701475&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B51"><span class="mixed-citation">Rosowsky A. (1999) <span class="ref-title">PT523 and other aminopterin analogs with a hemiphthaloyl-L-ornithine side chain: exceptionally tight-binding inhibitors of dihydrofolate reductase which are transported by the reduced folate carrier but cannot form polyglutamates</span>. <span class="ref-journal">Curr Med Chem</span>
<span class="ref-vol">6</span>:329&#x02013;352. [<a href="https://pubmed.ncbi.nlm.nih.gov/10101216" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Chem&amp;title=PT523+and+other+aminopterin+analogs+with+a+hemiphthaloyl-L-ornithine+side+chain:+exceptionally+tight-binding+inhibitors+of+dihydrofolate+reductase+which+are+transported+by+the+reduced+folate+carrier+but+cannot+form+polyglutamates&amp;author=A+Rosowsky&amp;volume=6&amp;publication_year=1999&amp;pages=329-352&amp;pmid=10101216&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B52"><span class="mixed-citation">Rothbart SB, Racanelli AC, Moran RG. (2010) <span class="ref-title">Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas</span>. <span class="ref-journal">Cancer Res</span>
<span class="ref-vol">70</span>:10299&#x02013;10309. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3059241/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21159649" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Pemetrexed+indirectly+activates+the+metabolic+kinase+AMPK+in+human+carcinomas&amp;author=SB+Rothbart&amp;author=AC+Racanelli&amp;author=RG+Moran&amp;volume=70&amp;publication_year=2010&amp;pages=10299-10309&amp;pmid=21159649&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B53"><span class="mixed-citation">Royer GP, Ikeda SI, Lee TK. (1977) <span class="ref-title">Substrate-induced conformational changes in lactate dehydrogenase. Proteolysis of the immobilized enzyme in the presence of specific substrates</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">252</span>:8775&#x02013;8777. [<a href="https://pubmed.ncbi.nlm.nih.gov/200617" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Substrate-induced+conformational+changes+in+lactate+dehydrogenase.+Proteolysis+of+the+immobilized+enzyme+in+the+presence+of+specific+substrates&amp;author=GP+Royer&amp;author=SI+Ikeda&amp;author=TK+Lee&amp;volume=252&amp;publication_year=1977&amp;pages=8775-8777&amp;pmid=200617&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B54"><span class="mixed-citation">Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA, Wallace RW, Hon CT, Kelly DR, Schmid SM, Gelder FB, Rado TA, et al. (1990) <span class="ref-title">A cystic fibrosis pancreatic adenocarcinoma cell line</span>. <span class="ref-journal">Proc Natl Acad Sci USA</span>
<span class="ref-vol">87</span>:4012&#x02013;4016. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC54034/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1692630" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=A+cystic+fibrosis+pancreatic+adenocarcinoma+cell+line&amp;author=RA+Schoumacher&amp;author=J+Ram&amp;author=MC+Iannuzzi&amp;author=NA+Bradbury&amp;author=RW+Wallace&amp;volume=87&amp;publication_year=1990&amp;pages=4012-4016&amp;pmid=1692630&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B55"><span class="mixed-citation">Shane B. (1989) <span class="ref-title">Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism</span>. <span class="ref-journal">Vitam Horm</span>
<span class="ref-vol">45</span>:263&#x02013;335. [<a href="https://pubmed.ncbi.nlm.nih.gov/2688305" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vitam+Horm&amp;title=Folylpolyglutamate+synthesis+and+role+in+the+regulation+of+one-carbon+metabolism&amp;author=B+Shane&amp;volume=45&amp;publication_year=1989&amp;pages=263-335&amp;pmid=2688305&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B56"><span class="mixed-citation">Stubbs M, McSheehy PMJ, Griffiths JR, Bashford CL. (2000) <span class="ref-title">Causes and consequences of tumour acidity and implications for treatment</span>. <span class="ref-journal">Mol Med Today</span>
<span class="ref-vol">6</span>:15&#x02013;19. [<a href="https://pubmed.ncbi.nlm.nih.gov/10637570" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Med+Today&amp;title=Causes+and+consequences+of+tumour+acidity+and+implications+for+treatment&amp;author=M+Stubbs&amp;author=PMJ+McSheehy&amp;author=JR+Griffiths&amp;author=CL+Bashford&amp;volume=6&amp;publication_year=2000&amp;pages=15-19&amp;pmid=10637570&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B57"><span class="mixed-citation">Subhi AL, Tang B, Balsara BR, Altomare DA, Testa JR, Cooper HS, Hoffman JP, Meropol NJ, Kruger WD. (2004) <span class="ref-title">Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer</span>. <span class="ref-journal">Clin Cancer Res</span>
<span class="ref-vol">10</span>:7290&#x02013;7296. [<a href="https://pubmed.ncbi.nlm.nih.gov/15534104" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Loss+of+methylthioadenosine+phosphorylase+and+elevated+ornithine+decarboxylase+is+common+in+pancreatic+cancer&amp;author=AL+Subhi&amp;author=B+Tang&amp;author=BR+Balsara&amp;author=DA+Altomare&amp;author=JR+Testa&amp;volume=10&amp;publication_year=2004&amp;pages=7290-7296&amp;pmid=15534104&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B58"><span class="mixed-citation">Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO, Jr, Chu TM. (1986) <span class="ref-title">Characterization of a new primary human pancreatic tumor line</span>. <span class="ref-journal">Cancer Invest</span>
<span class="ref-vol">4</span>:15&#x02013;23. [<a href="https://pubmed.ncbi.nlm.nih.gov/3754176" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Invest&amp;title=Characterization+of+a+new+primary+human+pancreatic+tumor+line&amp;author=MH+Tan&amp;author=NJ+Nowak&amp;author=R+Loor&amp;author=H+Ochi&amp;author=AA+Sandberg&amp;volume=4&amp;publication_year=1986&amp;pages=15-23&amp;pmid=3754176&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B59"><span class="mixed-citation">Tibbetts AS, Appling DR. (2010) <span class="ref-title">Compartmentalization of Mammalian folate-mediated one-carbon metabolism</span>. <span class="ref-journal">Annu Rev Nutr</span>
<span class="ref-vol">30</span>:57&#x02013;81. [<a href="https://pubmed.ncbi.nlm.nih.gov/20645850" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Nutr&amp;title=Compartmentalization+of+Mammalian+folate-mediated+one-carbon+metabolism&amp;author=AS+Tibbetts&amp;author=DR+Appling&amp;volume=30&amp;publication_year=2010&amp;pages=57-81&amp;pmid=20645850&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B60"><span class="mixed-citation">Unal ES, Zhao R, Qiu A, Goldman ID. (2008) <span class="ref-title">N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT)</span>. <span class="ref-journal">Biochim Biophys Acta</span>
<span class="ref-vol">1778</span>:1407&#x02013;1414. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2762823/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18405659" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;title=N-linked+glycosylation+and+its+impact+on+the+electrophoretic+mobility+and+function+of+the+human+proton-coupled+folate+transporter+(HsPCFT)&amp;author=ES+Unal&amp;author=R+Zhao&amp;author=A+Qiu&amp;author=ID+Goldman&amp;volume=1778&amp;publication_year=2008&amp;pages=1407-1414&amp;pmid=18405659&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B61"><span class="mixed-citation">Wang B, Wang W, Zhu Z, Zhang X, Tang F, Wang D, Liu X, Yan X, Zhuang H. (2017) <span class="ref-title">Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma</span>. <span class="ref-journal">Clin Neurol Neurosurg</span>
<span class="ref-vol">154</span>:28&#x02013;33. [<a href="https://pubmed.ncbi.nlm.nih.gov/28107674" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Neurol+Neurosurg&amp;title=Mitochondrial+serine+hydroxymethyltransferase+2+is+a+potential+diagnostic+and+prognostic+biomarker+for+human+glioma&amp;author=B+Wang&amp;author=W+Wang&amp;author=Z+Zhu&amp;author=X+Zhang&amp;author=F+Tang&amp;volume=154&amp;publication_year=2017&amp;pages=28-33&amp;pmid=28107674&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B62"><span class="mixed-citation">Wang L, Desmoulin SK, Cherian C, Polin L, White K, Kushner J, Fulterer A, Chang M-H, Mitchell-Ryan S, Stout M, et al. (2011) <span class="ref-title">Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits &#x003b2;-glycinamide ribonucleotide formyltransferase</span>. <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">54</span>:7150&#x02013;7164. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3209708/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21879757" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Synthesis,+biological,+and+antitumor+activity+of+a+highly+potent+6-substituted+pyrrolo[2,3-d]pyrimidine+thienoyl+antifolate+inhibitor+with+proton-coupled+folate+transporter+and+folate+receptor+selectivity+over+the+reduced+folate+carrier+that+inhibits+&#x003b2;-glycinamide+ribonucleotide+formyltransferase&amp;author=L+Wang&amp;author=SK+Desmoulin&amp;author=C+Cherian&amp;author=L+Polin&amp;author=K+White&amp;volume=54&amp;publication_year=2011&amp;pages=7150-7164&amp;pmid=21879757&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B63"><span class="mixed-citation">Wang L, Wallace A, Raghavan S, Deis SM, Wilson MR, Yang S, Polin L, White K, Kushner J, Orr S, et al. (2015) <span class="ref-title">6-Substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as targeted antifolates for folate receptor &#x003b1; and the proton-coupled folate transporter in human tumors</span>. <span class="ref-journal">J Med Chem</span>
<span class="ref-vol">58</span>:6938&#x02013;6959. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4714714/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26317331" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=6-Substituted+pyrrolo[2,3-d]pyrimidine+thienoyl+regioisomers+as+targeted+antifolates+for+folate+receptor+&#x003b1;+and+the+proton-coupled+folate+transporter+in+human+tumors&amp;author=L+Wang&amp;author=A+Wallace&amp;author=S+Raghavan&amp;author=SM+Deis&amp;author=MR+Wilson&amp;volume=58&amp;publication_year=2015&amp;pages=6938-6959&amp;pmid=26317331&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B64"><span class="mixed-citation">Wong SC, Proefke SA, Bhushan A, Matherly LH. (1995) <span class="ref-title">Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">270</span>:17468&#x02013;17475. [<a href="https://pubmed.ncbi.nlm.nih.gov/7615551" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Isolation+of+human+cDNAs+that+restore+methotrexate+sensitivity+and+reduced+folate+carrier+activity+in+methotrexate+transport-defective+Chinese+hamster+ovary+cells&amp;author=SC+Wong&amp;author=SA+Proefke&amp;author=A+Bhushan&amp;author=LH+Matherly&amp;volume=270&amp;publication_year=1995&amp;pages=17468-17475&amp;pmid=7615551&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B65"><span class="mixed-citation">Wu M, Arimura GK, Yunis AA. (1977) <span class="ref-title">Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells</span>. <span class="ref-journal">Biochemistry</span>
<span class="ref-vol">16</span>:1908&#x02013;1913. [<a href="https://pubmed.ncbi.nlm.nih.gov/15590" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Purification+and+characterization+of+a+plasminogen+activator+secreted+by+cultured+human+pancreatic+carcinoma+cells&amp;author=M+Wu&amp;author=GK+Arimura&amp;author=AA+Yunis&amp;volume=16&amp;publication_year=1977&amp;pages=1908-1913&amp;pmid=15590&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B66"><span class="mixed-citation">Wu M, Wanggou S, Li X, Liu Q, Xie Y. (2017) <span class="ref-title">Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas</span>. <span class="ref-journal">OncoTargets Ther</span>
<span class="ref-vol">10</span>:3781&#x02013;3788. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5538688/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28794642" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=OncoTargets+Ther&amp;title=Overexpression+of+mitochondrial+serine+hydroxyl-methyltransferase+2+is+associated+with+poor+prognosis+and+promotes+cell+proliferation+and+invasion+in+gliomas&amp;author=M+Wu&amp;author=S+Wanggou&amp;author=X+Li&amp;author=Q+Liu&amp;author=Y+Xie&amp;volume=10&amp;publication_year=2017&amp;pages=3781-3788&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B67"><span class="mixed-citation">Yang M, Vousden KH. (2016) <span class="ref-title">Serine and one-carbon metabolism in cancer</span>. <span class="ref-journal">Nat Rev Cancer</span>
<span class="ref-vol">16</span>:650&#x02013;662. [<a href="https://pubmed.ncbi.nlm.nih.gov/27634448" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Serine+and+one-carbon+metabolism+in+cancer&amp;author=M+Yang&amp;author=KH+Vousden&amp;volume=16&amp;publication_year=2016&amp;pages=650-662&amp;pmid=27634448&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B68"><span class="mixed-citation">Ye J, Fan J, Venneti S, Wan YW, Pawel BR, Zhang J, Finley LW, Lu C, Lindsten T, Cross JR, et al. (2014) <span class="ref-title">Serine catabolism regulates mitochondrial redox control during hypoxia</span>. <span class="ref-journal">Cancer Discov</span>
<span class="ref-vol">4</span>:1406&#x02013;1417. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4258153/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25186948" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Discov&amp;title=Serine+catabolism+regulates+mitochondrial+redox+control+during+hypoxia&amp;author=J+Ye&amp;author=J+Fan&amp;author=S+Venneti&amp;author=YW+Wan&amp;author=BR+Pawel&amp;volume=4&amp;publication_year=2014&amp;pages=1406-1417&amp;pmid=25186948&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B69"><span class="mixed-citation">Zhang C, Samanta D, Lu H, Bullen JW, Zhang H, Chen I, He X, Semenza GL. (2016a) <span class="ref-title">Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m<sup>6</sup>A-demethylation of NANOG mRNA</span>. <span class="ref-journal">Proc Natl Acad Sci USA</span>
<span class="ref-vol">113</span>:E2047&#x02013;E2056. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4833258/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27001847" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Hypoxia+induces+the+breast+cancer+stem+cell+phenotype+by+HIF-dependent+and+ALKBH5-mediated+m6A-demethylation+of+NANOG+mRNA&amp;author=C+Zhang&amp;author=D+Samanta&amp;author=H+Lu&amp;author=JW+Bullen&amp;author=H+Zhang&amp;volume=113&amp;publication_year=2016a&amp;pages=E2047-E2056&amp;pmid=27001847&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B70"><span class="mixed-citation">Zhang L, Chen Z, Xue D, Zhang Q, Liu X, Luh F, Hong L, Zhang H, Pan F, Liu Y, et al. (2016b) <span class="ref-title">Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker</span>. <span class="ref-journal">Oncol Rep</span>
<span class="ref-vol">36</span>:2489&#x02013;2500. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5055214/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27666119" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Rep&amp;title=Prognostic+and+therapeutic+value+of+mitochondrial+serine+hydroxyl-methyltransferase+2+as+a+breast+cancer+biomarker&amp;author=L+Zhang&amp;author=Z+Chen&amp;author=D+Xue&amp;author=Q+Zhang&amp;author=X+Liu&amp;volume=36&amp;publication_year=2016b&amp;pages=2489-2500&amp;pmid=27666119&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B71"><span class="mixed-citation">Zhao R, Diop-Bove N, Visentin M, Goldman ID. (2011) <span class="ref-title">Mechanisms of membrane transport of folates into cells and across epithelia</span>. <span class="ref-journal">Annu Rev Nutr</span>
<span class="ref-vol">31</span>:177&#x02013;201. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3885234/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21568705" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Nutr&amp;title=Mechanisms+of+membrane+transport+of+folates+into+cells+and+across+epithelia&amp;author=R+Zhao&amp;author=N+Diop-Bove&amp;author=M+Visentin&amp;author=ID+Goldman&amp;volume=31&amp;publication_year=2011&amp;pages=177-201&amp;pmid=21568705&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B72"><span class="mixed-citation">Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID. (2009) <span class="ref-title">A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis</span>. <span class="ref-journal">J Biol Chem</span>
<span class="ref-vol">284</span> (<span class="ref-iss">7</span>):4267&#x02013;4274. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2640977/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19074442" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=A+role+for+the+proton-coupled+folate+transporter+(PCFT-SLC46A1)+in+folate+receptor-mediated+endocytosis&amp;author=R+Zhao&amp;author=SH+Min&amp;author=Y+Wang&amp;author=E+Campanella&amp;author=PS+Low&amp;volume=284&amp;issue=7&amp;publication_year=2009&amp;pages=4267-4274&amp;pmid=19074442&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B73"><span class="mixed-citation">Zheng Y, Lin TY, Lee G, Paddock MN, Momb J, Cheng Z, Li Q, Fei DL, Stein BD, Ramsamooj S, et al. (2018) <span class="ref-title">Mitochondrial one-carbon pathway supports cytosolic folate integrity in cancer cells</span>. <span class="ref-journal">Cell</span>
<span class="ref-vol">175</span> (<span class="ref-iss">6</span>):1546&#x02013;1560.e17. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6568313/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30500537" ref="reftype=pubmed&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Mitochondrial+one-carbon+pathway+supports+cytosolic+folate+integrity+in+cancer+cells&amp;author=Y+Zheng&amp;author=TY+Lin&amp;author=G+Lee&amp;author=MN+Paddock&amp;author=J+Momb&amp;volume=175&amp;issue=6&amp;publication_year=2018&amp;pages=1546-1560.e17&amp;pmid=30500537&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=6877291&amp;issue-id=345997&amp;journal-id=830&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Molecular Pharmacology</span> are provided here courtesy of <strong>American Society for Pharmacology and Experimental Therapeutics</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC6877291/pdf/mol.119.117937.pdf" class="int-view">PDF (1.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/6877291/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/6877291/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="6877291" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6877291%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="OqpBGrwgE68xD0HXzgfY4gsWs6QcaWbicDMHaQuA1KmAnNtzJEDfYgfcjKBHdrzO">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6877291%2F&amp;text=Cellular%20Pharmacodynamics%20of%20a%20Novel%20Pyrrolo%5B3%2C2-d%5Dpyrimidine%20Inhibitor%20Targeting%20Mitochondrial%20and%20Cytosolic%20One-Carbon%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6877291%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877291/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC6877291/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/31707355/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC6877291/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/31707355/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC6877291/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/6877291/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC6877291/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
